<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharm Biol</journal-id><journal-id journal-id-type="iso-abbrev">Pharm Biol</journal-id><journal-title-group><journal-title>Pharmaceutical Biology</journal-title></journal-title-group><issn pub-type="ppub">1388-0209</issn><issn pub-type="epub">1744-5116</issn><publisher><publisher-name>Taylor &#x00026; Francis</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39996320</article-id><article-id pub-id-type="pmc">PMC11864034</article-id>
<article-id pub-id-type="doi">10.1080/13880209.2025.2467374</article-id><article-id pub-id-type="publisher-id">2467374</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version><article-categories><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Antidepressant activity of flavones from traditional Chinese medicine: a meta-analysis</article-title><alt-title alt-title-type="left-running-head">Q. Wang et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Qing</given-names></name><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AF0002" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Youyuan</given-names></name><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AF0003" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Mi</surname><given-names>Xue</given-names></name><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AF0002" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Caiyan</given-names></name><xref rid="AF0002" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Ma</surname><given-names>Wei</given-names></name><xref rid="AF0002" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Xia</surname><given-names>Changbo</given-names></name><xref rid="AF0004" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Hanqing</given-names></name><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AF0003" ref-type="aff">c</xref><xref rid="AF0005" ref-type="aff">e</xref><xref rid="AN0001" ref-type="corresp"/></contrib><aff id="AF0001"><label>a</label><institution>College of Pharmacy, Ningxia Medical University</institution>, <city>Yinchuan</city>, <country>China</country></aff><aff id="AF0002"><label>b</label><institution>Department of Pharmacy, The First People&#x02019;s Hospital of Yinchuan</institution>, <city>Yinchuan</city>, <country>China</country></aff><aff id="AF0003"><label>c</label><institution>Ningxia Regional Characteristic Traditional Chinese Medicine Collaborative Innovation Center Co-constructed by the Province and Ministry, Ningxia Engineering and Technology Research Center for Modernization of Regional Characteristic Traditional Chinese Medicine, Ningxia Medical University</institution>, <city>Yinchuan</city>, <country>China</country></aff><aff id="AF0004"><label>d</label><institution>Department of Pharmacy, Central&#x02019;s Hospital of Xinxiang</institution>, <city>Xinxiang</city>, <country>China</country></aff><aff id="AF0005"><label>e</label><institution>Key Laboratory of Ningxia Minority Medicine Modernization, Ministry of Education, Ningxia Medical University</institution>, <city>Yinchuan</city>, <country>China</country></aff></contrib-group><author-notes><fn id="AUFN1"><p>Supplemental data for this article can be accessed online at <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">https://doi.org/10.1080/13880209.2025.2467374</ext-link>.</p></fn><corresp id="AN0001">CONTACT Hanqing Wang <email xlink:href="mailto:wwwhhq@163.com">wwwhhq@163.com</email>
<institution>School of Pharmacy, Ningxia Medical University</institution>, <city>Yinchuan</city>
<postal-code>750004</postal-code>, <country>China</country>.</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><volume>63</volume><issue>1</issue><fpage seq="14">156</fpage><lpage>169</lpage><pub-history><event event-type="received"><date><day>11</day><month>9</month><year>2024</year></date></event><event event-type="revised"><date><day>26</day><month>1</month><year>2025</year></date></event><event event-type="accepted"><date><day>10</day><month>2</month><year>2025</year></date></event><event event-type="tagger"><event-desc>KnowledgeWorks Global Ltd.</event-desc><date><day>24</day><month>2</month><year>2025</year></date></event><event event-type="build-issue-online"><event-desc>published online in a building issue</event-desc><date><day>24</day><month>2</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#x000a9; 2025 The Author(s). Published by Informa UK Limited, trading as Taylor &#x00026; Francis Group.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="IPHB_63_2467374.pdf"/><abstract><title>Abstract</title><sec><title>Context</title><p>Flavones, the key active components in Traditional Chinese Medicine (TCM), have demonstrated antidepressant activity. Given the numerous animal studies conducted, a systematic analysis is essential to provide a valuable reference for future research.</p></sec><sec><title>Object</title><p>This study investigated the antidepressant activity of flavones based on animal models and summarized the underlying mechanisms.</p></sec><sec><title>Methods</title><p>We systematically searched 7 bibliographic Databases as of August 12, 2023, such as Web of Science, PubMed, China National Knowledge Infrastructure, etc. The meta-analysis was performed using either the random or fixed-effect model, supplemented by trial sequential analysis (TSA). The Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach was used to assess the quality of evidence.</p></sec><sec><title>Results</title><p>A total of 25 studies involving 458 mice were included, identifying five flavones (baicalin, baicalein, apigenin, luteolin, vitexin) with antidepressant activity. Compared to the control group, flavones significantly reduced immobility time in forced swimming and tail suspension tests. Flavones also decreased serum and hippocampal levels of interleukin (IL)-1&#x003b2; and tumor necrosis factor-alpha (TNF-&#x003b1;), reduced nuclear factor kappa B (NF-&#x003ba;B) levels, and increased brain-derived neurotrophic factor (BDNF) levels. Relative to the positive group, flavones raised IL-6, sucrose preference rate, and corticosterone (CORT) levels, with no significant differences in other factors. The TSA showed the efficacy of flavones for treating depression with adequate &#x02018;information size&#x02019; for the primary outcome.</p></sec><sec><title>Conclusions</title><p>The results demonstrate that flavones exert protective effects against depression in mice, primarily by stimulating neurotrophic factors and modulating inflammatory pathways. These findings emphasize their potential as promising candidates for the development of novel antidepressant therapies.</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>Depression</kwd><kwd>flavones</kwd><kwd>animal studies</kwd><kwd>meta-analysis</kwd><kwd>mechanisms</kwd></kwd-group><support-group><funding-group><award-group><funding-source>
<institution-wrap><institution>National Natural Science Foundation of China</institution><institution-id institution-id-type="open-funder-registry">10.13039/501100001809</institution-id></institution-wrap>
</funding-source><award-id>82160860</award-id></award-group><award-group><funding-source>
<institution-wrap><institution>Key research and development projects of Ningxia</institution></institution-wrap>
</funding-source><award-id>2021BEG02040</award-id></award-group><funding-statement>This study was supported by the National Natural Science Foundation of China (82160860) , the Key research and development projects of Ningxia (2021BEG02040) and the Leading Talent Cultivation Project in Science and Technology of Ningxia Hui Autonomous Region&#x02019;s (2023GKLRLX14).</funding-statement></funding-group></support-group><counts><fig-count count="8"/><table-count count="2"/><page-count count="14"/><word-count count="9303"/></counts></article-meta></front><body><sec sec-type="intro" disp-level="1" id="S0001"><title>Introduction</title><p>Traditional Chinese Medicine (TCM) is one of the most ancient healing systems, boasting a rich history of over two millennia of accumulated knowledge and practical application. TCM is considered a complementary or alternative medical system in most Western countries. It is estimated that millions of patients worldwide use TCM or related practices (Li <xref rid="CIT0018" ref-type="bibr">2022</xref>), ranging from treating the common cold to chronic diseases such as diabetes and ischemic stroke (Shen and Yin <xref rid="CIT0036" ref-type="bibr">2021</xref>; Zhu et&#x000a0;al. <xref rid="CIT0050" ref-type="bibr">2022</xref>). It is also worth emphasizing that many contemporary pharmaceuticals originate from herbal and natural sources. For instance, substances like St. John&#x02019;s wort, curcumin, and oligosaccharides in Morindae Officinalis Radix have demonstrated efficacy in addressing mild depression.</p><p>Depression is the most common life-threatening and debilitating mental disorder that features abnormalities in mode and manifests as depressed mood, fatigue, irritability, cognitive impairment, and loss of interest and joy (Hammen <xref rid="CIT0008" ref-type="bibr">2018</xref>). According to the World Health Organization, 300 million people worldwide suffer from depression. Notably, depression has a deleterious impact on human capital, interpersonal interactions, and social activities. It also poses an elevated risk of mortality due to suicide and other comorbid conditions (Herrman et&#x000a0;al. <xref rid="CIT0010" ref-type="bibr">2019</xref>). In contemporary medical practice, conventional antidepressant medications are widely used to treat depression. These medications encompass a range of classes, including tricyclic antidepressants (TCA), monoamine oxidase inhibitors (MAOIs), selective &#x000ad;serotonin reuptake Inhibitors (SSRIs), and selective 5-hydroxytryptamine (5-HT) reuptake inhibitors. Nevertheless, certain antidepressant drugs exhibit limited effectiveness in treating individuals who are resistant to standard therapies and are associated with significant adverse effects. These adverse effects encompass gastrointestinal disturbances, cardiovascular complications, headaches, and fatigue, which significantly impact patients&#x02019; quality of life and adherence to medication regimens (Solmi et&#x000a0;al. <xref rid="CIT0038" ref-type="bibr">2020</xref>). Therefore, new treatments must be urgently needed to develop novel therapeutic agents with more effective and fewer side effects to treat depression.</p><p>Flavones, which possess a C6-C3-C6 skeleton, mainly originate from plant metabolism and have demonstrated beneficial effects on various aspects of human physiology and health, such as antitumor, antiplatelet, anti-malarial, anti-inflammatory, anticonvulsant, and antidepressant properties (Khan et&#x000a0;al. <xref rid="CIT0015" ref-type="bibr">2018</xref>; Ko et&#x000a0;al. <xref rid="CIT0016" ref-type="bibr">2020</xref>; Melrose <xref rid="CIT0033" ref-type="bibr">2023</xref>). TCM has made substantial strides in the treatment of depression while minimizing adverse effects. Numerous animal experiments have been conducted to investigate the antidepressant properties of flavones in the context of depression. Previous meta-analyses (Jia et&#x000a0;al. <xref rid="CIT0012" ref-type="bibr">2023</xref>), encompassing a limited number of participants and studies, have suggested that flavonoids may alleviate symptoms of depression and anxiety, specifically targeting clinical patient populations. Additionally, another study has explored the antidepressant mechanisms attributed to flavonoids (Lysrayane et&#x000a0;al. <xref rid="CIT0031" ref-type="bibr">2021</xref>). Consequently, this study will undertake a systematic assessment of the effectiveness of flavones in depression-related animal models, thereby offering prospective avenues for subsequent clinical trials.</p></sec><sec sec-type="materials" disp-level="1" id="S0002"><title>Materials and methods</title><p>In this study, we complied with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting statement (Page et&#x000a0;al. <xref rid="CIT0034" ref-type="bibr">2021</xref>) and registered the study on the International Prospective Register of Systematic Reviews (registration no. CRD42023416795). The PRISMA checklists are available in Appendix Files, <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Table S1</ext-link>.</p><sec disp-level="2" id="S0002-S2001"><title>Search strategy</title><p>A total of seven databases were searched from their inception until March 16, 2023.The English databases include PubMed, Embase, Web of Science and the Chinese databases include Sinomed, China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database, and Wanfang. A combination of MeSH terms, Emtree headings, and keywords was used for &#x02018;depression&#x02019;, &#x02018;mice&#x02019;, &#x02018;apigenin&#x02019;, &#x02018;luteolin&#x02019;, &#x02018;baicalin&#x02019;, &#x02018;vitexin&#x02019;, and &#x02018;baicalein&#x02019;. The search strategy is presented in Appendix Files, <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Table S2</ext-link>.</p></sec><sec disp-level="2" id="S0002-S2002"><title>Study selection</title><p>Two investigators (W.Q. and M.X.) independently assessed the titles and retrieved the full-text studies in accordance with the inclusion criteria. The inclusion principles are as follows: (i) Animals: Mouse models of depression, without restrictions on age, sex, or duration of disease induction; (ii) Interventions: Treatment with flavone components, without limitations on administration methods, frequency, and dosage; (iii) Two comparison groups were used in this study. One is the model comparison, which was treated with a vehicle, distilled water, or saline after successful depression modeling. The other is the positive medicine comparison, treated with antidepressant drugs after successful depression modeling; (iv) Outcomes: The primary outcomes were behavioral tests of animals, including the tail suspension test (TST), forced swimming test (FST), open field test (OFT), and the sucrose preference test (SPT). The secondary outcomes included pro-inflammatory cytokines, such as interleukin-1&#x003b2; (IL-1&#x003b2;) levels, interleukin-6 (IL-6) levels, tumor necrosis factor-alpha (TNF-&#x003b1;) levels, serum corticosterone levels, brain-derived neurotrophic factor (BDNF) contents, and the level of nuclear factor kappa B (NF-&#x003ba;B); (v) Studies: The study design included controlled <italic toggle="yes">in vivo</italic> experiments with a control group, but was not restricted to randomized controls. The exclusion criteria were as follows: (i) studies lacking data from the depression model group or the antidepressant drugs group; (ii) studies involving flavone combinations with other compounds and treatments or association with other interventions; (iii) studies with duplicate publication or that failed to provide the required outcomes; (iv) studies that were conducted <italic toggle="yes">in vitro</italic>.</p></sec><sec disp-level="2" id="S0002-S2003"><title>Data extraction</title><p>The data, including the characteristics of studies, model, sex, weight, age, number of animals included, dose, time of intervention, and method of administration, was extracted from the included studies by two investigators independently. We first attempted to extract data from tables or figures; when these were not reported, we attempted to extract data from the bar plots of each study through the WebPlotDigitizer program. To comprehensively elucidate the efficacy of all flavones, we selected a regimen involving a higher dosage. We resolved discrepancies through discussion and, if necessary, adjudication by a third investigator (L.Y.Y).</p></sec><sec disp-level="2" id="S0002-S2004"><title>Quality assessment</title><p>The risk of bias was independently evaluated by W.Q and M.X using the Systematic Review Center for Laboratory Experimentation (SYRCLE) Risk of Bias tool (Hooijmans et&#x000a0;al. <xref rid="CIT0011" ref-type="bibr">2014</xref>). If discrepancies existed, L.Y.Y participated in the evaluation. The domains assessed included sequence generation, baseline characteristics, allocation concealment, random housing, blinding (performance bias), random outcome assessment, blinding (detection bias), incomplete outcome data, selective outcome reporting, and other sources of bias. Assessment results were categorized as &#x02018;low risk of bias&#x02019;, &#x02018;high risk of bias&#x02019;, and &#x02018;unclear risk of bias&#x02019;.</p></sec><sec disp-level="2" id="S0002-S2005"><title>Statistical analysis</title><p>We performed the meta-analysis using RevMan 5.4.1 and Stata 14.0. Mean differences (MDs) with 95% confidence intervals (95% CIs) were shown for continuous data. Heterogeneity was assessed using the &#x003c7;<sup>2</sup> test and <italic toggle="yes">I<sup>2</sup></italic> statistics. Due to the lack of significant heterogeneity (<italic toggle="yes">p</italic>&#x02009;&#x02265;&#x02009;0.10, <italic toggle="yes">I<sup>2</sup></italic> &#x02264; 50%), a fixed-effect model was used. Trial sequential analysis (TSA) was conducted with the primary outcome indicators TST, FST, SPT and OFT utilizing TSA software version 0.9.5.10 to evaluate the reliability of the evidence and to determine if the sample size has reached the desired sample size.</p></sec><sec disp-level="2" id="S0002-S2006"><title>Subgroup and sensitivity analysis</title><p>We conducted subgroup analyses based on the type of flavone, dose and method of administration. We assessed publication bias for the primary outcome using funnel plot asymmetry and Egger&#x02019;s test, provided that more than ten studies were available. Sensitivity analyses were conducted to verify the robustness of the results by excluding one study per time and repeating the meta-analysis. Stata version 14.0 software was utilized for the publication bias and sensitivity analyses.</p></sec><sec disp-level="2" id="S0002-S2007"><title>GRADE evaluation</title><p>Two investigators assessed the quality of evidence using GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) (Guyatt et&#x000a0;al. <xref rid="CIT0007" ref-type="bibr">2011</xref>). We downgraded each outcome based on bias, inconsistency, indirectness, imprecision, and publication bias.</p></sec></sec><sec sec-type="results" disp-level="1" id="S0003"><title>Results</title><sec disp-level="2" id="S0003-S2001"><title>Study selection</title><p>After removing duplicate publications, 303 studies were screened by reviewing their titles and abstracts. Ultimately, 37 full texts were assessed for eligibility, of which 25 were selected for further study. A visual description of the study selection process in the PRISMA flowchart in <xref rid="F0001" ref-type="fig">Figure 1</xref>.</p><fig position="float" id="F0001"><label>Figure 1.</label><caption><p>Preferred reporting items for systematic reviews and meta-analyses (PRISMA) flowchart.</p></caption><graphic xlink:href="IPHB_A_2467374_F0001_C" content-type="color" position="float"/></fig></sec><sec disp-level="2" id="S0003-S2002"><title>Characteristics of included studies</title><p>Compared to female mice, male mice were more commonly used in these studies, with the number of animals per group ranging from 6 to 12. In these 25 literatures, a total of five depression models were investigated: chronic unpredictable mild stress (CUMS), chronic mild stress (CMS), corticosterone (CORT), chronic restraint stress (CRS), and lipopolysaccharide-induced depression. Among these, the CUMS model was the most frequently used. Additionally, two of the included studies did not explicitly describe the depression model used (Can et&#x000a0;al. <xref rid="CIT0003" ref-type="bibr">2013</xref>; Al-Yamani et&#x000a0;al. <xref rid="CIT0002" ref-type="bibr">2022</xref>). For the flavone components with antidepressant activity, baicalin, baicalein, apigenin, luteolin, and vitexin were reported, with baicalin receiving the most attention. Typically, mice were orally administered flavones and antidepressant drugs. The characteristics of the included studies are summarized in <xref rid="t0001" ref-type="table">Table 1</xref>.</p><table-wrap position="float" id="t0001"><label>Table 1.</label><caption><p>Characteristics of the included studies.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th rowspan="2" align="left">References</th><th rowspan="2" align="center">Modeling</th><th rowspan="2" align="center">Sex and Species/</th><th rowspan="2" align="center">Group (n)</th><th rowspan="2" align="center">Weight (g)/age (w)</th><th colspan="3" align="center">Intervention Measures<hr/></th><th rowspan="2" align="center">Drug delivery method</th><th rowspan="2" align="center">Outcomes</th></tr><tr><th align="center">Model</th><th align="center">Positive</th><th align="center">Flavones</th></tr></thead><tbody valign="top"><tr><td align="left">Can et&#x000a0;al. <xref rid="CIT0003" ref-type="bibr">2013</xref></td><td align="left">NR</td><td align="left">Male BALB/c</td><td align="char" char=".">8</td><td align="left">30&#x02013;35/6</td><td align="left">NR</td><td align="left">Reb (20&#x02009;mg/kg) once</td><td align="left">Vit (30&#x02009;mg/kg) once</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a</italic>
</td></tr><tr><td align="left">Liu et&#x000a0;al. <xref rid="CIT0027" ref-type="bibr">2013</xref></td><td align="left">CUMS</td><td align="left">Male ICR</td><td align="char" char=".">10</td><td align="left">18&#x02013;20/NR</td><td align="left">NR&#x02009;+&#x02009;CUMS 6w</td><td align="left">NR</td><td align="left">Lut (6&#x02009;mg/kg) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, b</italic>
</td></tr><tr><td align="left">Li et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2015a</xref></td><td align="left">LPS</td><td align="left">Male ICR</td><td align="char" char=".">10</td><td align="left">18&#x02013;22/NR</td><td align="left">Sal for 7d&#x02009;+&#x02009;LPS (0.5&#x02009;mg/kg/d) for 7d</td><td align="left">Flu (20&#x02009;mg/kg/d) for 7d&#x02009;+&#x02009;LPS (0.5&#x02009;mg/kg/d) for 7d</td><td align="left">Api (50&#x02009;mg/kg/d) for 7d&#x02009;+&#x02009;LPS (0.5&#x02009;mg/kg/d) for 7d</td><td align="center">i. p.</td><td align="center">
<italic toggle="yes">a, c, d, e, f, i</italic>
</td></tr><tr><td align="left">Li et&#x000a0;al. <xref rid="CIT0020" ref-type="bibr">2015b</xref></td><td align="left">CORT</td><td align="left">Male ICR</td><td align="char" char=".">10</td><td align="left">18&#x02013;22/NR</td><td align="left">CORT (40&#x02009;mg/kg/d) for 3w</td><td align="left">Flu (20&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CORT (40&#x02009;mg/kg/d) for 3w</td><td align="left">BA (20&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CORT (40&#x02009;mg/kg/d) for 3w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">b, c, g, j</italic>
</td></tr><tr><td align="left">Sheng et&#x000a0;al. <xref rid="CIT0037" ref-type="bibr">2016</xref></td><td align="left">CORT</td><td align="left">Male ICR</td><td align="char" char=".">10</td><td align="left">18&#x02013;22/NR</td><td align="left">Sal for 21d&#x02009;+&#x02009;CORT 3w</td><td align="left">Flu (20&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CORT 3w</td><td align="left">BA (20&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CORT 3w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">b, c</italic>
</td></tr><tr><td align="left">Weng et&#x000a0;al. <xref rid="CIT0042" ref-type="bibr">2016</xref></td><td align="left">CORT</td><td align="left">Male ICR</td><td align="char" char=".">8</td><td align="left">24&#x02009;&#x000b1;&#x02009;2/NR</td><td align="left">CORT (40&#x02009;mg/kg/d) for 3w</td><td align="left">Flu (20&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CORT (40&#x02009;mg/kg/d) for 3w</td><td align="left">Api (40&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CORT (40&#x02009;mg/kg/d) 3w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">b, c, g, j</italic>
</td></tr><tr><td align="left">Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref></td><td align="left">CUMS</td><td align="left">Male ICR</td><td align="char" char=".">12</td><td align="left">18&#x02013;22/NR</td><td align="left">Sal for 21d&#x02009;+&#x02009;CUMS 8w</td><td align="left">Flu (20&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 8w</td><td align="left">BA (60&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 8w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, b, c, d, e, f, h</italic>
</td></tr><tr><td align="left">Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>a</td><td align="left">CUMS</td><td align="left">Male SPF ICR</td><td align="char" char=".">12</td><td align="left">18&#x02013;22/NR</td><td align="left">Sal for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">Flu (20&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">BA (50&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, b, c, d, e, f, h, i</italic>
</td></tr><tr><td align="left">Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>b</td><td align="left">CUMS</td><td align="left">Male ICR</td><td align="char" char=".">10</td><td align="left">30&#x02009;&#x000b1;&#x02009;3/NR</td><td align="left">Sal for 21d&#x02009;+&#x02009;CUMS 3w</td><td align="left">Flu (5.2&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 3w</td><td align="left">BA (12&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 3w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">b, c</italic>
</td></tr><tr><td align="left">Lu et&#x000a0;al. <xref rid="CIT0030" ref-type="bibr">2019</xref></td><td align="left">CMS</td><td align="left">Male ICR</td><td align="char" char=".">10</td><td align="left">20&#x02013;25/8</td><td align="left">NR&#x02009;+&#x02009;CUMS 3w</td><td align="left">Flu (5.2&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 3w</td><td align="left">BA (100&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 3w</td><td align="center">i. p.</td><td align="center">
<italic toggle="yes">b, c</italic>
</td></tr><tr><td align="left">Zhang et&#x000a0;al. <xref rid="CIT0045" ref-type="bibr">2019a</xref></td><td align="left">CORT</td><td align="left">Male C57BL/6</td><td align="char" char=".">8</td><td align="left">18&#x02013;22/8</td><td align="left">Sal for 28d&#x02009;+&#x02009;CUMS 8w</td><td align="left">Flu (18&#x02009;mg/kg) for 28d&#x02009;+&#x02009;CORT 8w</td><td align="left">BA (160&#x02009;mg/kg/d)for 28d&#x02009;+&#x02009;CORT 8w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, b</italic>
</td></tr><tr><td align="left">Zhang et&#x000a0;al. <xref rid="CIT0046" ref-type="bibr">2019b</xref></td><td align="left">CUMS</td><td align="left">Male ICR</td><td align="char" char=".">10</td><td align="left">23&#x02013;26/NR</td><td align="left">Sal for 21d&#x02009;+&#x02009;CUMS 6 w</td><td align="left">Flu (15&#x02009;mg/kg) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">BA (60&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, c, d</italic>
</td></tr><tr><td align="left">Zhang et&#x000a0;al. <xref rid="CIT0047" ref-type="bibr">2019c</xref></td><td align="left">CRS</td><td align="left">Male BALB/c</td><td align="char" char=".">10</td><td align="left">18&#x02013;20/6</td><td align="left">NR&#x02009;+&#x02009;CUMS 5w</td><td align="left">Flu (25&#x02009;mg/kg/d) for 14d&#x02009;+&#x02009;CUMS 5w</td><td align="left">Api (60&#x02009;mg/kg/d) for 14d&#x02009;+&#x02009;CUMS 5w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">c, d</italic>
</td></tr><tr><td align="left">Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref></td><td align="left">CUMS</td><td align="left">Male C57BL/6</td><td align="char" char=".">8</td><td align="left">NR/ 7 to 8</td><td align="left">Sal for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">Flu (20&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">BA (50&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, b, c, d, e, f, h</italic>
</td></tr><tr><td align="left">Zhao et&#x000a0;al. <xref rid="CIT0048" ref-type="bibr">2020</xref></td><td align="left">CORT</td><td align="left">Female C57BL/6J</td><td align="char" char=".">10</td><td align="left">18&#x02013;22/6 to 8</td><td align="left">Sal for 42d&#x02009;+&#x02009;CORT (40&#x02009;mg/kg/d) 6w</td><td align="left">ES (10&#x02009;mg/kg) for 21d&#x02009;+&#x02009;CORT (40&#x02009;mg/kg/d) 6w</td><td align="left">BA (60&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CORT (40&#x02009;mg/kg/d) 6w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, b, c, g</italic>
</td></tr><tr><td align="left">Jia et&#x000a0;al. <xref rid="CIT0013" ref-type="bibr">2021</xref></td><td align="left">CUMS</td><td align="left">Male ICR</td><td align="char" char=".">10</td><td align="left">24&#x02009;&#x000b1;&#x02009;2/7</td><td align="left">Sal for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">Flu (10&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">BA (50&#x02009;mg/kg/d)for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, c</italic>
</td></tr><tr><td align="left">Xiao et&#x000a0;al. <xref rid="CIT0043" ref-type="bibr">2021</xref></td><td align="left">CUMS</td><td align="left">Male ICR</td><td align="char" char=".">9</td><td align="left">20&#x02013;25/7 to 8</td><td align="left">NR+ CUMS 6w</td><td align="left">Flu (10&#x02009;mg/kg) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">BA (100&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, c</italic>
</td></tr><tr><td align="left">Alghamdi et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2022</xref></td><td align="left">CMS</td><td align="left">NR Albino</td><td align="char" char=".">8</td><td align="left">20&#x02013;25/10 to 14</td><td align="left">Sal for 21d&#x02009;+&#x02009;CUMS 3w</td><td align="left">Imipramine (15&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CMS 3w</td><td align="left">Api (50&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CMS 3w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, c, g</italic>
</td></tr><tr><td align="left">Al-Yamani et&#x000a0;al. <xref rid="CIT0002" ref-type="bibr">2022</xref></td><td align="left">NR</td><td align="left">Either sex Albino</td><td align="char" char=".">6</td><td align="left">20&#x02013;25/<break/>NR</td><td align="left">NR</td><td align="left">Flu (30&#x02009;mg/kg) for three times</td><td align="left">Api (50&#x02009;mg/kg/d) for three times</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a</italic>
</td></tr><tr><td align="left">Liu et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2022a</xref></td><td align="left">LPS</td><td align="left">Male C57BL/6</td><td align="char" char=".">6</td><td align="left">NR/NR</td><td align="left">Sal&#x02009;+&#x02009;LPS (5&#x02009;mg/kg) once</td><td align="center">NR</td><td align="left">Ba (3&#x02009;mg/kg) once&#x02009;+&#x02009;LPS (5&#x02009;mg/kg) once</td><td align="center">i. p.</td><td align="center">
<italic toggle="yes">a, b, e, f, h, i</italic>
</td></tr><tr><td align="left">Li et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2022</xref></td><td align="left">LPS</td><td align="left">Male C57BL/6</td><td align="char" char=".">8</td><td align="left">20&#x02009;&#x000b1;&#x02009;2/8</td><td align="left">0.5% CMC-Na&#x02009;+&#x02009;LPS (1&#x02009;mg/kg) 3d</td><td align="center">NR</td><td align="left">Lut (50&#x02009;mg/kg) 3d&#x02009;+&#x02009;LPS (1&#x02009;mg/kg) 3d</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">b, c, e, h</italic>
</td></tr><tr><td align="left">Lu et&#x000a0;al. <xref rid="CIT0029" ref-type="bibr">2022</xref></td><td align="left">CUMS</td><td align="left">Male C57BL/6N</td><td align="char" char=".">9</td><td align="left">18&#x02013;20/6</td><td align="left">Sal for 28d&#x02009;+&#x02009;CUMS 10w</td><td align="left">Flu (10&#x02009;mg/kg/d) for 28d&#x02009;+&#x02009;CUMS 10w</td><td align="left">BA (10&#x02009;mg/kg/d) for 28d&#x02009;+&#x02009;CUMS 10w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">b, c</italic>
</td></tr><tr><td align="left">Wang et al. <xref rid="CIT0041" ref-type="bibr">2023</xref></td><td align="left">CORT</td><td align="left">Male ICR</td><td align="char" char=".">8</td><td align="left">26&#x02009;&#x000b1;&#x02009;2/7</td><td align="left">NR&#x02009;+&#x02009;CORT (40&#x02009;mg/kg/d) 6w</td><td align="left">Flu (10&#x02009;mg/kg) for 21d&#x02009;+&#x02009;CORT (40&#x02009;mg/kg/d) 6w</td><td align="left">BA (50&#x02009;mg/kg) for 21d&#x02009;+&#x02009;CORT (40&#x02009;mg/kg/d) 6w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, b, c</italic>
</td></tr><tr><td align="left">Jin et&#x000a0;al. <xref rid="CIT0014" ref-type="bibr">2023</xref></td><td align="left">CUMS</td><td align="left">Male C57BL/6N</td><td align="char" char=".">9</td><td align="left">16&#x02013;20/NR</td><td align="left">Sal for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">Flu (20&#x02009;mg/kg) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">BA (20&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, c</italic>
</td></tr><tr><td align="left">Ma et&#x000a0;al. <xref rid="CIT0032" ref-type="bibr">2023</xref></td><td align="left">CUMS</td><td align="left">Male ICR</td><td align="char" char=".">10</td><td align="left">25&#x02013;30/NR</td><td align="left">water or 0.4% DMSO&#x02009;+&#x02009;CUMS 6w</td><td align="left">Flu (20&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="left">BA (60&#x02009;mg/kg/d) for 21d&#x02009;+&#x02009;CUMS 6w</td><td align="center">i. g.</td><td align="center">
<italic toggle="yes">a, c</italic>
</td></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>Api: Apigenin; Ba: Baicalein; BA: baicalin; CMC-Na: sodium carboxymethyl cellulose; CMS: chronic mild stress; CORT: corticosterone; CRS: chronic restraint stress; CUMS: chronic unpredictable mild stress; DMSO: dimethylsulfoxide; Escitalopram: ES; Flu: fluoxetine; LPS: Lipopolysaccharide; Lut: Luteolin; Reb: Reboxetine; Saline: Sal; Vit: Vitexin; NR: not reported; i. g.: intragastric injection; i. p.:intraperitoneal injection; d: days; w: weeks; n: number.</p></fn><fn id="TF2"><p><italic toggle="yes">a</italic>: tail suspension test (TST), <italic toggle="yes">b</italic>: forced swimming test (FST), <italic toggle="yes">c</italic>: sucrose preference test (SPT), <italic toggle="yes">d</italic>: open field test (OFT), <italic toggle="yes">e</italic>: IL-1&#x003b2;, <italic toggle="yes">f</italic>: TNF-&#x003b1;, <italic toggle="yes">g</italic>: serum corticosterone levels, <italic toggle="yes">h</italic>: IL-6, <italic toggle="yes">i</italic>: NF-kb, <italic toggle="yes">j</italic>: brain-derived neurotrophic factor (BDNF).</p></fn></table-wrap-foot></table-wrap></sec><sec disp-level="2" id="S0003-S2003"><title>Quality assessment of the included studies</title><p>In the included literature, only one study described the specific randomization process in detail, while the rest mentioned &#x02018;random&#x02019; methods only when allocating the animals (Wang et&#x000a0;al. <xref rid="CIT0041" ref-type="bibr">2023</xref>). Twenty-three studies provided detailed descriptions of animal characteristics, ensuring similarity between groups. All studies were rated as unclear for allocation concealment due to the lack of detailed clarification regarding whether the animals were adequately concealed. Based on the descriptions of the experimental animals, the included studies were considered to be at low risk for issues with animal placement randomization. However, all were assessed as having an unclear risk in evaluating randomized outcomes. Experimental performers were blinded in two studies (Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref>; Liu et&#x000a0;al. <xref rid="CIT0028" ref-type="bibr">2019</xref>). No study described the assessment of outcomes in a randomized manner. Additionally, only four studies detailed the specific method of blinding used to evaluate outcomes (Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>; Zhang et&#x000a0;al. <xref rid="CIT0045" ref-type="bibr">2019a</xref>; Xiao et&#x000a0;al. <xref rid="CIT0043" ref-type="bibr">2021</xref>; Liu et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2022a</xref>). Due to missing data on the number of animals, six studies demonstrated a high risk of attrition bias (Li et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2015a</xref>; <xref rid="CIT0020" ref-type="bibr">2015b</xref>; Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref>; Zhang et&#x000a0;al. <xref rid="CIT0045" ref-type="bibr">2019a</xref>; Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>b; Li et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2022</xref>). The SYRCLE assessment of the risk of bias is shown in <xref rid="F0002" ref-type="fig">Figure 2</xref>.</p><fig position="float" id="F0002"><label>Figure 2.</label><caption><p>Risk of bias assessment table. (a) Risk of bias summary. (b) Risk of bias graph.</p></caption><graphic xlink:href="IPHB_A_2467374_F0002_C" content-type="color" position="float"/></fig></sec><sec disp-level="2" id="S0003-S2004"><title>Outcome measures</title><sec disp-level="3" id="S0003-S2004-S3001"><title>Behavioral tests</title><p>Seventeen studies involving 308 mice reported on the TST (Can et&#x000a0;al. <xref rid="CIT0003" ref-type="bibr">2013</xref>; Liu et&#x000a0;al. <xref rid="CIT0027" ref-type="bibr">2013</xref>; Li et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2015a</xref>; Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref>; Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>; Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>; Zhang et&#x000a0;al. <xref rid="CIT0045" ref-type="bibr">2019a</xref>; <xref rid="CIT0046" ref-type="bibr">2019b</xref>; Zhao et&#x000a0;al. <xref rid="CIT0048" ref-type="bibr">2020</xref>; Jia et&#x000a0;al. <xref rid="CIT0013" ref-type="bibr">2021</xref>; Xiao et&#x000a0;al. <xref rid="CIT0043" ref-type="bibr">2021</xref>; Alghamdi et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2022</xref>; Al-Yamani et&#x000a0;al. <xref rid="CIT0002" ref-type="bibr">2022</xref>; Liu et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2022a</xref>; Jin et&#x000a0;al. <xref rid="CIT0014" ref-type="bibr">2023</xref>; Ma et&#x000a0;al. <xref rid="CIT0032" ref-type="bibr">2023</xref>; Wang et&#x000a0;al. <xref rid="CIT0041" ref-type="bibr">2023</xref>). The results of the meta-analysis indicated that flavones significantly reduced the immobility time in TST compared with the model group [MD&#x02009;=&#x02009;&#x02212;44.71 (95% CI: &#x02212;54.22, &#x02212;35.21, <italic toggle="yes">I<sup>2</sup></italic> = 77%; <xref rid="F0003" ref-type="fig">Figure 3</xref>)].</p><fig position="float" id="F0003"><label>Figure 3.</label><caption><p>Forest plot for the effect of flavones on the tail suspension test.</p></caption><graphic xlink:href="IPHB_A_2467374_F0003_C" content-type="color" position="float"/></fig><p>A total of 15 studies, including (Liu et&#x000a0;al. <xref rid="CIT0027" ref-type="bibr">2013</xref>; Li et&#x000a0;al. <xref rid="CIT0020" ref-type="bibr">2015b</xref>; Sheng et&#x000a0;al. <xref rid="CIT0037" ref-type="bibr">2016</xref>; Weng et&#x000a0;al. <xref rid="CIT0042" ref-type="bibr">2016</xref>; Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref>; Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>, <xref rid="CIT0023" ref-type="bibr">2019</xref>; Lu et&#x000a0;al. <xref rid="CIT0030" ref-type="bibr">2019</xref>; Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>; Zhang et&#x000a0;al. <xref rid="CIT0045" ref-type="bibr">2019a</xref>; Zhao et&#x000a0;al. <xref rid="CIT0048" ref-type="bibr">2020</xref>; Li et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2022</xref>; Lu et&#x000a0;al. <xref rid="CIT0029" ref-type="bibr">2022</xref>; Liu et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2022a</xref>; Wang et&#x000a0;al. <xref rid="CIT0041" ref-type="bibr">2023</xref>), involving 278 mice, reported on the FST. The pooled results indicated that flavones significantly reduced the immobility time in the FST compared to the model group [MD&#x02009;=&#x02009;&#x02212;40.79 (95% CI: &#x02212;44.64, &#x02212;36.93, <italic toggle="yes">I<sup>2</sup></italic> = 31%; <xref rid="F0004" ref-type="fig">Figure 4</xref>)].</p><fig position="float" id="F0004"><label>Figure 4.</label><caption><p>Forest plot for the effect of flavones on the forced swimming test.</p></caption><graphic xlink:href="IPHB_A_2467374_F0004_C" content-type="color" position="float"/></fig><p>Twenty studies (Li et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2015a</xref>, <xref rid="CIT0020" ref-type="bibr">2015b</xref>; Sheng et&#x000a0;al. <xref rid="CIT0037" ref-type="bibr">2016</xref>; Weng et&#x000a0;al. <xref rid="CIT0042" ref-type="bibr">2016</xref>; Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref>; Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>, <xref rid="CIT0023" ref-type="bibr">2019</xref>; Lu et&#x000a0;al. <xref rid="CIT0030" ref-type="bibr">2019</xref>; Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>; Zhang et&#x000a0;al. <xref rid="CIT0046" ref-type="bibr">2019b</xref>, <xref rid="CIT0047" ref-type="bibr">2019c</xref>; Zhao et&#x000a0;al. <xref rid="CIT0048" ref-type="bibr">2020</xref>; Jia et&#x000a0;al. <xref rid="CIT0013" ref-type="bibr">2021</xref>; Xiao et&#x000a0;al. <xref rid="CIT0043" ref-type="bibr">2021</xref>; Alghamdi et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2022</xref>; Li et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2022</xref>; Lu et&#x000a0;al. <xref rid="CIT0029" ref-type="bibr">2022</xref>; Jin et&#x000a0;al. <xref rid="CIT0014" ref-type="bibr">2023</xref>; Ma et&#x000a0;al. <xref rid="CIT0032" ref-type="bibr">2023</xref>; Wang et&#x000a0;al. <xref rid="CIT0041" ref-type="bibr">2023</xref>), including 374 mice assessed SPT. The meta-analysis revealed that, compared with the model group, flavones significantly increased the sucrose preference rate in an animal model of depression [MD = 18.55 (95% CI: 13.89, 23.21, <italic toggle="yes">I<sup>2</sup></italic> = 82%; <xref rid="F0005" ref-type="fig">Figure 5</xref>)].</p><fig position="float" id="F0005"><label>Figure 5.</label><caption><p>Forest plot for the effect of flavones on the sucrose preference test.</p></caption><graphic xlink:href="IPHB_A_2467374_F0005_C" content-type="color" position="float"/></fig><p>Four studies involving 80 mice have reported the crossing number (Li et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2015a</xref>; Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref>; Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>; Zhang et&#x000a0;al. <xref rid="CIT0045" ref-type="bibr">2019a</xref>). The pooled effects indicate that the administration of flavones was associated with a significant difference when compared to the model group [MD = 32.46 (95% CI: 15.55, 49.37, <italic toggle="yes">I<sup>2</sup></italic> = 74%; <xref rid="F0006" ref-type="fig">Figure 6a</xref>)]; Additionally, three studies recorded the distance travelled (Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>; Zhang et&#x000a0;al. <xref rid="CIT0047" ref-type="bibr">2019c</xref>; Ma et&#x000a0;al. <xref rid="CIT0032" ref-type="bibr">2023</xref>), and the meta-analysis showed no significant difference in the distance travelled between the flavones group and the model group [MD = 75.14 (95% CI: &#x02212;24.74, 175.03, <italic toggle="yes">I<sup>2</sup></italic> = 62%; <xref rid="F0006" ref-type="fig">Figure 6b</xref>)].</p><fig position="float" id="F0006"><label>Figure 6.</label><caption><p>Forest plot for the effect of flavones on the (a) crossing number and (b) distance traveled.</p></caption><graphic xlink:href="IPHB_A_2467374_F0006_C" content-type="color" position="float"/></fig></sec><sec disp-level="3" id="S0003-S2004-S3002"><title>Inflammatory cytokinesl</title><p>Three studies reported IL-1&#x003b2; levels in the blood (Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>; Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>; Liu et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2022a</xref>); the results indicated a significant difference in reducing IL-1&#x003b2; levels between the flavone and model groups [MD&#x02009;=&#x02009;&#x02212;17.74 (95% CI: &#x02212;25.27, &#x02212;10.2, <italic toggle="yes">I<sup>2</sup></italic> = 0%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S1</ext-link>)]. Three studies assessed the IL-1&#x003b2; levels in the hippocampus (pg/mg) (Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref>; Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>; Li et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2022</xref>), and the meta-analysis showed that there was no significant difference in reducing IL-1&#x003b2; levels between flavones and model groups [MD&#x02009;=&#x02009;&#x02212;14.81 (95% CI: &#x02212;37.79, 8.16, <italic toggle="yes">I<sup>2</sup></italic> = 94%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S2</ext-link>)]. Two studies presented IL-1&#x003b2; levels in the hippocampus (pg/ml) (Li et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2015a</xref>; Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>). The pooled effects showed a significant difference in reducing IL-1&#x003b2; levels between flavones and model groups [MD&#x02009;=&#x02009;&#x02212;31.63 (95% CI: &#x02212;48.02, &#x02212;15.23, <italic toggle="yes">I<sup>2</sup></italic> = 82%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S3</ext-link>)].</p><p>Three studies presented the result of IL-6 levels in the blood (Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>; Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>; Liu et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2022a</xref>); the findings indicated that there was no significant difference in reducing IL-6 levels between the flavone group and the model group [MD&#x02009;=&#x02009;&#x02212;287.9 (95% CI: &#x02212;607.32, 31.53, <italic toggle="yes">I<sup>2</sup></italic> = 95%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S4</ext-link>)]. A meta-analysis of three studies (Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref>; Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>; Li et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2022</xref>) revealed a significant difference in the reduction of IL-6 levels in the hippocampus between the flavone group and the model group [MD&#x02009;=&#x02009;&#x02212;43.68 (95% CI: &#x02212;80.05, &#x02212;7.31, <italic toggle="yes">I<sup>2</sup></italic> = 87%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S5</ext-link>)].</p><p>Effect sizes for TNF-&#x003b1; levels were pooled from three studies (Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>; Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>; Liu et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2022a</xref>). The pooled results showed that flavones significantly decreased TNF-&#x003b1; levels in the blood compared with those in the model group [MD&#x02009;=&#x02009;&#x02212;22.23 (95% CI: &#x02212;28.5, &#x02212;15.95, <italic toggle="yes">I<sup>2</sup></italic> = 37%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S6</ext-link>)]. Two comparisons reported TNF-&#x003b1; levels in the hippocampus (pg/mg) (Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref>; Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>). The pooled effects showed no significant difference between the flavones and model groups [MD&#x02009;=&#x02009;&#x02212;145.19 (95% CI: &#x02212;379.98, 89.6, <italic toggle="yes">I<sup>2</sup></italic> = 96%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S7</ext-link>)]. Two comparisons reported the TNF-&#x003b1; levels in the hippocampus (pg/ml) (Li et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2015a</xref>; Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>), and the pooled results indicated that the administration of flavones was associated with a significant difference compared to the model group [MD&#x02009;=&#x02009;&#x02212;41.27 (95% CI: &#x02212;49.57, &#x02212;32.97, <italic toggle="yes">I<sup>2</sup></italic> = 34%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S8</ext-link>)].</p><p>Concerning the effect on NF-&#x003ba;B levels in the prefrontal cortex (hippocampus), two studies reported this outcome (Li et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2015a</xref>; Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>). The pooled result showed that flavones significantly decreased NF-&#x003ba;B levels compared to the model group [MD&#x02009;=&#x02009;&#x02212;0.23 (95% CI: &#x02212;0.3, &#x02212;0.16, <italic toggle="yes">I<sup>2</sup></italic> = 0%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S9</ext-link>)].</p></sec><sec disp-level="3" id="S0003-S2004-S3003"><title>Other indexes</title><p>A total of three studies reported CORT levels (Li et&#x000a0;al. <xref rid="CIT0020" ref-type="bibr">2015b</xref>; Weng et&#x000a0;al. <xref rid="CIT0042" ref-type="bibr">2016</xref>; Zhao et&#x000a0;al. <xref rid="CIT0048" ref-type="bibr">2020</xref>), and the results demonstrated that there was no significant difference between flavones and the model group [MD&#x02009;=&#x02009;&#x02212;30.9 (95% CI: &#x02212;80.39, 18.6, <italic toggle="yes">I<sup>2</sup></italic> = 96%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S10</ext-link>)].</p><p>Meta-analysis of three studies reported BDNF levels (Li et&#x000a0;al. <xref rid="CIT0020" ref-type="bibr">2015b</xref>; Weng et&#x000a0;al. <xref rid="CIT0042" ref-type="bibr">2016</xref>; Lu et&#x000a0;al. <xref rid="CIT0030" ref-type="bibr">2019</xref>), and the results revealed that flavones can increase the BDNF levels in comparison with those in the model group [MD = 0.65 (95% CI: 0.41, 0.9, <italic toggle="yes">I<sup>2</sup></italic> = 78%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S11</ext-link>)].</p></sec><sec disp-level="3" id="S0003-S2004-S3004"><title>Flavones compared with positive group</title><p>Compared with positive group, no significant difference was found between the positive group and the flavones group in reducing TST time [MD = 5.56 (95% CI: &#x02212;1.83, 12.94, <italic toggle="yes">I<sup>2</sup></italic> = 64%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S12</ext-link>)], FST time [MD&#x02009;=&#x02009;&#x02212;0.55 (95% CI: &#x02212;9.38, 8.27, <italic toggle="yes">I<sup>2</sup></italic> = 78%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S13</ext-link>)], distance travelled [MD = 3.16 (95% CI: &#x02212;91.76, 98.07, <italic toggle="yes">I<sup>2</sup></italic> = 53%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S14</ext-link>)], crossing number [MD = 3.42 (95% CI: &#x02212;10.84, 17.68, <italic toggle="yes">I<sup>2</sup></italic> = 51%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S15</ext-link>)], IL-1&#x003b2; in blood level (pg/ml) [MD = 6.5 (95% CI: &#x02212;1.49, 14.49, <italic toggle="yes">I<sup>2</sup></italic> = 0%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S16</ext-link>)], IL-1&#x003b2; in hippocampus level (pg/mg) [MD = 1.5 (95% CI: &#x02212;11.26, 14.27, <italic toggle="yes">I<sup>2</sup></italic> = 75%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S17</ext-link>)], IL-1&#x003b2; in hippocampus level (pg/ml) [MD = 0.14 (95% CI: &#x02212;22.07, 22.36, <italic toggle="yes">I<sup>2</sup></italic> = 67%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S18</ext-link>)], IL-6 in hippocampus level (pg/mg) [MD = 0.59 (95% CI: &#x02212;12.5, 13.68, <italic toggle="yes">I<sup>2</sup></italic> = 0%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S19</ext-link>)], TNF-&#x003b1; in blood level (pg/ml) [MD = 6.46 (95% CI: 0.32, 12.61, <italic toggle="yes">I<sup>2</sup></italic> = 16%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S20</ext-link>)], TNF-&#x003b1; in hippocampus level (pg/mg) [MD = 25.71 (95% CI: &#x02212;27.9, 79.32, <italic toggle="yes">I<sup>2</sup></italic> = 70%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S21</ext-link>)], TNF-&#x003b1; in hippocampus level (pg/ml) [MD&#x02009;=&#x02009;&#x02212;3.88 (95% CI: &#x02212;18.92, 11.17, <italic toggle="yes">I<sup>2</sup></italic> = 79%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S22</ext-link>)], NF-kb in blood level (pg/ml) [MD = 0.07 (95% CI: &#x02212;0.06, 0.2, <italic toggle="yes">I<sup>2</sup></italic> = 80%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S23</ext-link>)] and BDNF levels [MD = 0.05 (95% CI: &#x02212;0.08, 0.19, <italic toggle="yes">I<sup>2</sup></italic> = 34%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S24</ext-link>)].</p><p>The pooled result showed that flavones increase IL-6 in blood level (pg/ml) [MD = 9.82 (95% CI: 3.56, 16.09, <italic toggle="yes">I<sup>2</sup></italic> = 8%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S25</ext-link>)], sucrose preference rate [MD = 2.47 (95% CI: 0.84, 4.1, <italic toggle="yes">I<sup>2</sup></italic> = 32%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S26</ext-link>)] and CORT levels [MD&#x02009;=&#x02009;&#x02212;10.48 (95% CI: &#x02212;19.43, &#x02212;1.54, <italic toggle="yes">I<sup>2</sup></italic> = 0%; Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S27</ext-link>)] in an animal model of depression.</p></sec></sec><sec disp-level="2" id="S0003-S2005"><title>Publication bias</title><p>Egger&#x02019;s test indicated that there was no publication bias with the TST, FST, and SPT in the model group (<italic toggle="yes">p</italic>&#x02009;=&#x02009;0.078, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.329, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.980) and the positive group (<italic toggle="yes">p</italic>&#x02009;=&#x02009;0.28, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.225, <italic toggle="yes">p</italic>&#x02009;=&#x02009;0.195). Since fewer than ten studies were included, a publication bias assessment was not conducted for the other outcomes.</p></sec><sec disp-level="2" id="S0003-S2006"><title>Subgroup and sensitivity analyses</title><p>Considering the high heterogeneity in the meta-analyses, we conducted further subgroup analyses based on the type of flavone (vitexin, apigenin, baicalin, baicalein, luteolin), the method of administration (intragastrically vs. intraperitoneally) and the dose. The flavone dosage was categorized into three groups: low (less than 50&#x02009;mg/kg/day), medium (greater than 50&#x02009;mg/kg/day and less than 100&#x02009;mg/kg/day), and high (greater than 100&#x02009;mg/kg/day). For the TST, FST, and SPT, the subgroup analyses did not reveal significant differences between the flavone group and the model or positive groups based on either the type of flavone, dose and the method of administration.</p><p>In assessing the antidepressant effects of flavones compared to the model group, a subgroup analysis of different types of flavones was conducted for the TST. It was observed that the heterogeneity decreased in the baicalin group. The heterogeneity of the TST significantly decreased from 77% to 26%, suggesting that the type of flavone and the dosage were the primary contributors to heterogeneity. However, the heterogeneity of the apigenin group remained high. Similarly, sources of heterogeneity in the SPT results were analyzed, and even after subgroup analysis, the heterogeneity remained high (<xref rid="F0007" ref-type="fig">Figure 7</xref>).</p><fig position="float" id="F0007"><label>Figure 7.</label><caption><p>Subgroup analysis of pooled estimates of behavioral tests on the (a) tail suspension test, (b) forced swimming test and (c) sucrose preference test.</p></caption><graphic xlink:href="IPHB_A_2467374_F0007_B" content-type="black-white" position="float"/></fig><p>On the antidepressant effects of flavones compared with the positive group in meta-analyses, for the TST, the heterogeneity decreased sharply from 63% to 0%, and the results were unaffected by the exclusion of the study by Jin et&#x000a0;al. (<xref rid="CIT0014" ref-type="bibr">2023</xref>). For the FST, subgroup analyses of the outcomes showed a high degree of heterogeneity (<ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S28</ext-link>).</p><p>When we conducted a sensitivity analysis by excluding studies that did not explicitly indicate the missing data, the results of the TST, FST, and SPT remained relatively unchanged, suggesting that the results were stable (<ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figures S29&#x02013;S34</ext-link>).</p></sec><sec disp-level="2" id="S0003-S2007"><title>Quality of evidence</title><p>Utilizing the GRADE approach, we assessed the quality of evidence for the reported outcomes. In the model group, the evidence quality was classified as moderate (<italic toggle="yes">n</italic>&#x02009;=&#x02009;4) and low (<italic toggle="yes">n</italic>&#x02009;=&#x02009;12). The findings from the model group are summarized in <xref rid="t0002" ref-type="table">Table 2</xref>, while those from the positive group are detailed in Appendix Files, <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Tab. S3</ext-link>.</p><table-wrap position="float" id="t0002"><label>Table 2.</label><caption><p>Assessment of quality and summarizing the findings using the GRADE approach.</p></caption><!--OASIS TABLE HERE--><table frame="hsides" rules="groups"><colgroup><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/><col width="80pt"/></colgroup><thead><tr><th colspan="7" align="left">Certainty assessment<hr/></th><th align="center">No of animals</th><th colspan="2" align="center">Effect<hr/></th><th rowspan="2" align="center">Quality of the evidence (GRADE)</th></tr><tr><th align="left">Outcomes</th><th align="center">No of studies</th><th align="center">Risk of bias</th><th align="center">Inconsistency</th><th align="center">Indirectness</th><th align="center">Imprecision</th><th align="center">Other considerations</th><th align="center">Flavones /Model</th><th align="center">Relative (95% CI)</th><th align="center">Absolute</th></tr></thead><tbody valign="top"><tr><td align="left">TST</td><td align="char" char=".">17</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Not serious<xref rid="TF6" ref-type="table-fn"><sup>b</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">154/154</td><td align="left">&#x02013;</td><td align="left">MD 44.71 lower (54.22 lower to 35.21 lower)</td><td align="left">&#x02a01;&#x02a01;&#x02a01;&#x025ef; Moderate</td></tr><tr><td align="left">FST</td><td align="char" char=".">15</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Not serious<xref rid="TF6" ref-type="table-fn"><sup>b</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">139/139</td><td align="left">&#x02013;</td><td align="left">MD 40.79 lower (44.64 lower to 36.93 lower)</td><td align="left">&#x02a01;&#x02a01;&#x02a01;&#x025ef; Moderate</td></tr><tr><td align="left">SPT</td><td align="char" char=".">20</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Serious<xref rid="TF7" ref-type="table-fn"><sup>c</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">187/187</td><td align="left">&#x02013;</td><td align="left">MD 18.55 higher (13.89 higher to 23.21 higher)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">OFT (crossing number)</td><td align="char" char=".">4</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Serious<xref rid="TF7" ref-type="table-fn"><sup>c</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">40/40</td><td align="left">&#x02013;</td><td align="left">MD 32.46 higher (15.55 higher to 49.37 higher)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">OFT (distance traveled)</td><td align="char" char=".">3</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Serious<xref rid="TF7" ref-type="table-fn"><sup>c</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">30/30</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 75.14 higher (24.74 lower to 175.03 higher)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">IL-1&#x003b2; levels in blood (pg/ml)</td><td align="char" char=".">3</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">20/20</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 17.74 lower (25.27 lower to 10.2 lower)</td><td align="left">&#x02a01;&#x02a01;&#x02a01;&#x025ef; Moderate</td></tr><tr><td align="left">IL-1&#x003b2; levels in the hippocampus (pg/mg)</td><td align="char" char=".">3</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Serious<xref rid="TF7" ref-type="table-fn"><sup>c</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">24/24</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 14.81 lower (37.79 lower to 8.16 higher)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">IL-1&#x003b2; levels in the hippocampus (pg/ml)</td><td align="char" char=".">2</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Serious<xref rid="TF7" ref-type="table-fn"><sup>c</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">12/12</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 31.63 lower (48.02 lower to 15.23 lower)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">IL-6 levels in the blood (pg/ml)</td><td align="char" char=".">3</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Serious<xref rid="TF7" ref-type="table-fn"><sup>c</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">20/20</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 287.9 lower (607.32 lower to 31.53 higher)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">IL-6 levels in the hippocampus (pg/mg)</td><td align="char" char=".">3</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Serious<xref rid="TF7" ref-type="table-fn"><sup>c</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">24/24</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 43.68 lower (80.05 lower to 7.31 lower)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">TNF-&#x003b1; levels in the blood (pg/ml)</td><td align="char" char=".">3</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">20/20</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 22.23 lower (28.5 lower to 15.95 lower)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">TNF-&#x003b1; levels in the hippocampus (pg/mg)</td><td align="char" char=".">2</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Serious<xref rid="TF7" ref-type="table-fn"><sup>c</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">16/16</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 145.19 lower (379.98 lower to 89.6 higher)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">TNF-&#x003b1; levels in the hippocampus (pg/ml)</td><td align="char" char=".">2</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">12/12</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 41.27 lower (49.57 lower to 32.97 lower)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">NF-&#x003ba;B levels in the prefrontal cortex</td><td align="char" char=".">2</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">9/9</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 0.23 lower (0.3 lower to 0.16 lower)</td><td align="left">&#x02a01;&#x02a01;&#x02a01;&#x025ef; Moderate</td></tr><tr><td align="left">CORT levels</td><td align="char" char=".">3</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Serious<xref rid="TF7" ref-type="table-fn"><sup>c</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">28/28</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 30.9 lower (80.39 lower to 18.6 higher)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr><tr><td align="left">BDNF levels</td><td align="char" char=".">3</td><td align="left">Serious<xref rid="TF5" ref-type="table-fn"><sup>a</sup></xref></td><td align="left">Serious<xref rid="TF7" ref-type="table-fn"><sup>c</sup></xref></td><td align="left">Not serious</td><td align="left">Not serious</td><td align="left">None</td><td align="char" char=".">21/21</td><td align="left">
<bold>-</bold>
</td><td align="left">MD 0.65 higher (0.41 higher to 0.9 higher)</td><td align="left">&#x02a01;&#x02a01;&#x025ef;&#x025ef; Low</td></tr></tbody></table><table-wrap-foot><fn id="TF3"><p><italic toggle="yes">Note:</italic> High quality: we are very confident that the true effect lies close to that of the estimate of the effect. Moderate quality: we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. Low quality: our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. Very low quality: we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.</p></fn><fn id="TF4"><p>CI: confidence interval; MD: mean difference.</p></fn><fn id="TF5"><label>
<sup>a</sup>
</label><p>The included studies were significantly biased with respect to randomization methods, allocation concealment, blind method, and incomplete outcome dat.</p></fn><fn id="TF6"><label>
<sup>b</sup>
</label><p>There is no serious inconsistency since the sources of heterogeneity were identified.</p></fn><fn id="TF7"><label>
<sup>c</sup>
</label><p>Heterogeneity (<italic toggle="yes">I<sup>2</sup></italic> &#x0003e; 50%, <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) was found.</p></fn></table-wrap-foot></table-wrap></sec><sec disp-level="2" id="S0003-S2008"><title>Trial sequential analysis</title><p>The result of TSA on TST, FST, SPT and OFT (crossing number) showed that the cumulative z-value surpassed both the conventional boundary and the TSA threshold, thereby achieving the Required Information Size (RIS). However, for the distance traveled, the cumulative z-value failed to reach the RIS, though it did cross the TSA boundary value. Despite not achieving the anticipated sample size, clinical efficacy has been established. These findings demonstrate the effectiveness of flavones in treating depression in comparison with the model group (<xref rid="F0008" ref-type="fig">Figure 8</xref>).</p><fig position="float" id="F0008"><label>Figure 8.</label><caption><p>Trial sequential analysis for (a) tail suspension test, (b) forced swimming test, (c) sucrose preference test, (d) OFT (crossing number) and (e) OFT (distance traveled).</p></caption><graphic xlink:href="IPHB_A_2467374_F0008_C" content-type="color" position="float"/></fig><p>The results of the TSA for TST, SPT, and OFT (crossing number) indicated that the cumulative Z-value surpassed both the conventional boundary and the TSA threshold, thereby achieving the Required Information Size (RIS). For the FST, the software reported that the first information fraction exceeded 100% of the RIS, suggesting that the available sample size was sufficient to provide statistically reliable conclusions. However, for the distance traveled, the cumulative Z-value did not reach the RIS, although it did surpass the TSA boundary value. These findings demonstrate the effectiveness of flavones in treating depression in comparison with the model group (<xref rid="F0008" ref-type="fig">Figure 8</xref>).</p><p>The findings indicate that additional studies are still required to confirm the comparative analysis of flavones and positive control drugs in the treatment of depression (Appendix Files <ext-link xlink:href="10.1080/13880209.2025.2467374" ext-link-type="doi">Figure S35</ext-link>).</p></sec></sec><sec sec-type="discussion" disp-level="1" id="S0004"><title>Discussion</title><sec disp-level="2" id="S0004-S2001"><title>Efficacy of flavones</title><p>Globally, depression is one of the leading causes of disability and mobility impairment (Herrman et&#x000a0;al. <xref rid="CIT0010" ref-type="bibr">2019</xref>). Depression may be caused by multiple factors, and its complex mechanism makes prevention and treatment challenging (Harmer et&#x000a0;al. <xref rid="CIT0009" ref-type="bibr">2017</xref>). Consequently, it is essential to identify more efficacious treatments. Natural compounds have been investigated for their antidepressant properties. Polyphenols like flavones, naturally occurring polyphenols, have been extensively researched for their pharmacological properties, particularly their antidepressant properties. Studies with rodents have shown that they reverse depressive behaviors. Several previous <italic toggle="yes">in vivo</italic> preclinical studies in animal models and human patients had reported the therapeutic potential of flavones on depression (Al-Yamani et&#x000a0;al. <xref rid="CIT0002" ref-type="bibr">2022</xref>; Zhang et&#x000a0;al. <xref rid="CIT0044" ref-type="bibr">2023</xref>). For instance, A flavonoid-rich fraction from <italic toggle="yes">Scutellaria baicalensis</italic>, an herb used in traditional Chinese medicine, may provide antidepressant effects (Wang and Gao <xref rid="CIT0040" ref-type="bibr">2024</xref>).</p><p>This meta-analysis included 458 mice. Based on the results of this meta-analysis, flavones are effective in a variety of experimental models. We observed that, compared to the model group, flavones demonstrated a significant reduction in immobility time in both FST and TST, increased SPT, elevated locomotor activity, and decreased levels of pro-inflammatory cytokines, namely IL-1&#x003b2;, IL-6, TNF-&#x003b1;, and NF-&#x003ba;B. These findings collectively suggest that flavones have the potential to significantly ameliorate depressive behavior, with their anti-inflammatory effects emerging as a plausible explanation for the observed protective outcomes.</p><p>In our meta-analysis, we observed a pronounced degree of heterogeneity in the primary outcomes, including TST, FST, and SPT, a phenomenon anticipated in animal experimental studies.This heterogeneity has a substantial impact on the robustness and reliability of our analytical results. The results of our subgroup analysis indicate that this high level of heterogeneity could potentially be attributed to variations in the types of flavones used, the doses of administered drugs and the design of animal experiments. The selection of flavones is of paramount importance in this context. Baicalin and its aglycone, baicalein, are flavonoid compounds isolated from the roots of <italic toggle="yes">Scutellaria baicalensis</italic>. Apigenin is a naturally derived compound that can be found abundantly in fruits and vegetables, while luteolin is widely distributed among plant species. Vitexin, classified as a flavone C-glucoside, is present in nutraceuticals and food items and has garnered attention owing to its potential antidepressant-like effects. These compounds demonstrate prominent biological activities, including anti-inflammatory, neuroprotective properties and antioxidant (Can et&#x000a0;al. <xref rid="CIT0003" ref-type="bibr">2013</xref>; Guo et&#x000a0;al. <xref rid="CIT0006" ref-type="bibr">2019</xref>; Zhang et&#x000a0;al. <xref rid="CIT0047" ref-type="bibr">2019c</xref>; Li et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2022</xref>).</p><p>According to subgroup analyses, the effects of baicalin, apigenin, luteolin, and vitexin treatments on depressive-like behaviors, as measured by FST and SPT, were not statistically significant compared to the control group. Nonetheless, the collective findings suggest that the administration of flavones demonstrated greater efficacy in alleviating depressive-like symptoms relative to the control group. Conversely, concerning TST, the observed difference in the effectiveness of apigenin in mitigating depressive behaviors in mice compared to the control group did not reach statistical significance. This outcome could potentially be attributed to the limited inclusion of studies. Notably, in two studies involving baicalin, data loss was documented in the reports of TST, FST, and SPT.</p><p>We conducted a subgroup analysis to assess the impact of different flavone doses. Our findings indicated that the administration of flavones at low doses did not result in notable improvements in behavioral performance compared to the outcomes observed in the groups receiving medium and high doses relative to the control group. Furthermore, our analysis demonstrated that, compared to the positive control group, interventions involving medium doses of flavones were more effective in improving behavioral outcomes than those using low doses.</p><p>However, since the animal models included in the study were all mouse models, we cannot determine whether the findings from these models can be reliably extrapolated to other animal models or clinical studies. Additionally, our study presents inconclusive results when comparing the efficacy of flavone compounds with positive control medications for treating depression, primarily due to the limited sample size of the included trials. Therefore, further evidence from clinical trials is needed to evaluate the efficacy of flavones, and several high-quality studies with larger sample sizes are necessary to confirm our findings. Moreover, analyzing the factors contributing to heterogeneity poses challenges. Due to the limited sample size, accurately identifying the precise causes of the observed high heterogeneity proved complex.</p></sec><sec disp-level="2" id="S0004-S2002"><title>Mechanisms</title><p>To date, the mechanism of action of antidepressants is recognized as multifaceted, encompassing increased neurotransmitter levels, receptor activity modulation, alterations in neuroplasticity, exertion of anti-inflammatory effects, and stimulation of neurotrophic factors (Liu et&#x000a0;al. <xref rid="CIT0024" ref-type="bibr">2015</xref>; Peng et&#x000a0;al. <xref rid="CIT0035" ref-type="bibr">2015</xref>). Each element contributes distinctively to the therapeutic impact of antidepressants, with the potential to operate independently or synergistically to alleviate depressive symptoms. Current research on the antidepressant mechanisms of flavones primarily involves: (1) Elevation of the monoamine, including norepinephrine (NA), 5-HT, and dopamine (DA) pathways, are implicated in depression&#x02019;s pathophysiology (Dean and Keshavan <xref rid="CIT0005" ref-type="bibr">2017</xref>). Vitexin&#x02019;s antidepressant efficacy hinges on increased catecholamine levels and interactions with 5-HT<sub>1A</sub>, dopaminergic D<sub>1</sub>, D<sub>2</sub>, and D<sub>3</sub> receptors (Can et&#x000a0;al. <xref rid="CIT0003" ref-type="bibr">2013</xref>). Additionally, apigenin&#x02019;s antidepressant effects involve &#x003b1;-adrenergic, dopaminergic, and 5-HT<sub>3</sub> serotonergic receptors (Al-Yamani et&#x000a0;al. <xref rid="CIT0002" ref-type="bibr">2022</xref>); (2) Anti-inflammatory effects, increasing evidence associates inflammation with depression&#x02019;s etiology, inducing depressive behaviors (Dean and Keshavan <xref rid="CIT0005" ref-type="bibr">2017</xref>). Baicalin mitigates neuroinflammation and depressive-like symptoms by inhibiting toll-like receptor 4 <italic toggle="yes">via</italic> the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/forkhead box protein O1 (FoxO1) pathway, suppressing high mobility group box protein 1 (HMGB1)/toll-like receptor 4 (TLR4)/NF-&#x003ba;B pathways, and regulating N-methyl-D aspartate receptor (NMDAR)/subtype 2B (NR2B)- extracellular regulated kinase (ERK)1/2 to curb inflammation and oxidative stress (Zhong et&#x000a0;al. <xref rid="CIT0049" ref-type="bibr">2019</xref>; Liu et&#x000a0;al. <xref rid="CIT0022" ref-type="bibr">2022a</xref>). Apigenin reduces nitric-oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) expressions by activating NF-kB (Li et&#x000a0;al. <xref rid="CIT0019" ref-type="bibr">2015a</xref>), while luteolin promotes anti-neuroinflammatory and antidepressant effects by upregulating A20 and Nrf2 (Li et&#x000a0;al. <xref rid="CIT0021" ref-type="bibr">2022</xref>); (3) Regulation of the hypothalamic-pituitary-adrenal (HPA) axis, baicalin modulates the HPA axis by reducing serum corticosterone and increasing 11&#x003b2;-hydroxysteroid dehydrogenase-2 (11&#x003b2;-HSD2) and BDNF in the hippocampus (Li et&#x000a0;al. <xref rid="CIT0020" ref-type="bibr">2015b</xref>). It also remodels HPA axis feedback by normalizing glucocorticoid receptor (GR) nuclear translocation (Zhang et&#x000a0;al. <xref rid="CIT0045" ref-type="bibr">2019a</xref>) and activates the PI3K/AKT/glycogen synthase kinase 3&#x003b2; (GSK3&#x003b2;)/&#x003b2;-catenin pathway (Zhao et&#x000a0;al. <xref rid="CIT0048" ref-type="bibr">2020</xref>). (4) Promoting neurogenesis, baicalin has been demonstrated to reverse CUMS-induced reductions in protein kinase B (p-Akt), forkhead box transcription factor (FOXG1), and fibroblast growth factor (FGF2) (Zhang et&#x000a0;al. <xref rid="CIT0046" ref-type="bibr">2019b</xref>). BDNF, crucial for neuronal survival, is found to be reduced in the hippocampus of individuals with depression (Peng et&#x000a0;al. <xref rid="CIT0035" ref-type="bibr">2015</xref>; Colucci-D&#x02019;Amato et&#x000a0;al. <xref rid="CIT0004" ref-type="bibr">2020</xref>). Additionally, apigenin has been shown to modulate levels of corticosterone and increase BDNF in the hippocampus (Sheng et&#x000a0;al. <xref rid="CIT0037" ref-type="bibr">2016</xref>; Weng et&#x000a0;al. <xref rid="CIT0042" ref-type="bibr">2016</xref>). Baicalin&#x02019;s antidepressant effects involve BDNF/ERK/cAMP response element binding (CREB), BDNF/tropomyosin-related kinase B (TrkB)/ras-related C3 botulinum toxin substrate (Rac)/LIM kinase (LIMK) pathways (Lu et&#x000a0;al. <xref rid="CIT0030" ref-type="bibr">2019</xref>; Jia et&#x000a0;al. <xref rid="CIT0013" ref-type="bibr">2021</xref>), mammalian target of rapamycin (mTOR)/glycogen synthase kinase 3&#x003b2; (GSK3&#x003b2;) (Wang et&#x000a0;al. <xref rid="CIT0041" ref-type="bibr">2023</xref>) and Wnt/&#x003b2;-catenin signaling pathway (Xiao et&#x000a0;al. <xref rid="CIT0043" ref-type="bibr">2021</xref>); (5) Inhibition of oxidative stress. Various preclinical and clinical trials have shown that oxidative stress may be a potentially important parameter for depression (Alghamdi et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2022</xref>; Liu et&#x000a0;al. <xref rid="CIT0026" ref-type="bibr">2023</xref>). For instance, compared to the control group, apigenin alleviated CMS-induced emotional behaviours in mice by increasing the glutathione level and significantly decreasing malondialdehyde (MDA) and catalase levels in the brain (Alghamdi et&#x000a0;al. <xref rid="CIT0001" ref-type="bibr">2022</xref>). Additionally, luteolin diminished MDA levels, while the glutathione peroxidase (GSH) and superoxide dismutase (SOD) levels were decreased in the hippocampus of CUMS exposed mice and also reduced depression-like behaviours (Liu et&#x000a0;al. <xref rid="CIT0027" ref-type="bibr">2013</xref>); (6) Inhibition of neuronal apoptosis, another molecular mechanism that maintains cellular homeostasis, has recently been shown to be associated with the physiology of depression (Wang et&#x000a0;al. <xref rid="CIT0039" ref-type="bibr">2021</xref>). Based on several animal depression models, baicalin attenuated the behaviour of depression hippocampal neuronal apoptosis by regulating the silent information regulator sirtuin 1 (SIRT1)/polymerase-1 (PARP1) signaling pathway (Ma et&#x000a0;al. <xref rid="CIT0032" ref-type="bibr">2023</xref>) and inducing the expression of calbindin-D28K (Liu et&#x000a0;al. <xref rid="CIT0023" ref-type="bibr">2019</xref>); (7) Improvement of mitochondrial dysfunction. Jin et&#x000a0;al. discovered that baicalin might enhance nip-like protein (NIX)-mediated mitophagy through direct binding to adenosine monophosphate-activated protein kinase (AMPK) and activating the downstream step of the proliferator-activated receptor-gamma coactivator-1 (PGC-1) signaling pathway (Jin et&#x000a0;al. <xref rid="CIT0014" ref-type="bibr">2023</xref>). This mechanism may contribute to baicalin&#x02019;s antidepressant effects by upregulating genes related to enzymes in glycolysis and the tricarboxylic acid cycle, thereby improving mitochondrial function and increasing adenosine triphosphate (ATP) levels in the brain. Additionally, findings suggest that apigenin may facilitate autophagy <italic toggle="yes">via</italic> the AMPK/mammalian target of the rapamycin (mTOR) pathway, inducing antidepressive effects in mice subjected to chronic restraint stress (Zhang et&#x000a0;al. <xref rid="CIT0047" ref-type="bibr">2019c</xref>). (8) Regulation of the Gut&#x02013;Brain Axis, emerging preclinical studies have demonstrated that the changes in the composition and function of gut microbiota are associated with the development and progression of depression, primarily <italic toggle="yes">via</italic> the regulation of the gut-brain axis (Liu et&#x000a0;al. <xref rid="CIT0025" ref-type="bibr">2022b</xref>). Research demonstrating that quercetin may exert antidepressant effects by restoring gut microbiota balance thorough its targeted modulation of specific bacterial populations, including <italic toggle="yes">Romboutsia</italic>, <italic toggle="yes">Turicibacter</italic>, <italic toggle="yes">Faecalibaculum</italic>, and <italic toggle="yes">Bifidobacterium</italic>. Additionally, it may exert its effects by influencing brain metabolism (Li et&#x000a0;al. <xref rid="CIT0017" ref-type="bibr">2024</xref>).</p></sec><sec disp-level="2" id="S0004-S2003"><title>Strengths and limitations</title><p>This meta-analysis has several strengths. First, compared with previous research, our study is the first preclinical meta-analysis to assess the impact of flavones in combating depression in animal models. As a result of our findings, we can provide practical applications for transforming animal data from the laboratory to the bedside using evidence-based methods. Secondly, we performed a comparative analysis of the antidepressant effects of flavone compounds against both positive drugs and the model group. To further investigate the antidepressant effectiveness, we conducted subgroup analyses with different flavones and doses. Thirdly, we assessed the evidence using the GRADE system for evaluating the quality of evidence.</p><p>This meta-analysis has several limitations. Firstly, only a small number of studies with small sample sizes were included. Secondly, the acquisition of original data was incomplete, with some data points obtained using the WebPlotDigitizer program. As a result, there may be errors that could affect the accuracy of the results, potentially leading to measurement bias. Thirdly, the literature quality assessment using the risk of bias tool revealed a lack of high-quality studies, particularly in terms of randomization, blinding methods, and handling of missing data, which may contribute to selection bias. Biased or imprecise results and without rigorous evaluation, some preclinical animal studies supported by clinical research led to costly clinical research and withdrawal from the market afterward. The effects of drugs on human patients with depression can be better predicted in human models of depression that are of higher quality. To provide high-quality evidence, future research should focus on improving experimental methods, modeling approaches, and reporting animal experiments. Therefore, some conclusions in the present study should be interpreted with caution. As a result of this result, we should increase the sample size and standardize the experimental design in future studies to make the results more reliable.</p></sec></sec><sec sec-type="conclusions" disp-level="1" id="S0005"><title>Conclusions</title><p>In summary, our findings indicate that flavones can significantly ameliorate depression-like behaviors and enhance neurological function in animals exhibiting depressive symptoms. However, there is still a need for larger animal models and clinical trials to validate the results. Therefore, additional high-quality preclinical trials and clinical studies are essential before flavones can be applied in human treatments.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="SM0179" position="float" content-type="local-data"><caption><title>Supplementary_Material.pdf</title></caption><media xlink:href="IPHB_A_2467374_SM0179.pdf"/></supplementary-material></sec></body><back><ack><title>Acknowledgments</title><p>We would like to thank Dr. Gao Tiantian for her invaluable assistance in reviewing and revising the manuscript.</p></ack><sec disp-level="1" id="S0006"><title>Authors&#x02019; contributions</title><p>W.Q., W.H.Q. and L.Y.Y. designed the study; W.Q., L.Y.Y., M.X., Y.C.Y., M.W. and X.C.B. collected the data; W.Q., L.Y.Y., M.X., M.W. and X.C.B. were responsible for data analysis and interpretation; W.Q., W.H.Q. and L.Y.Y. wrote the manuscript; W.H.Q., Y.C.Y., and M.X. revised and reviewed the manuscript. All authors reviewed the manuscript.</p></sec><sec sec-type="COI-statement" disp-level="1" id="S0007"><title>Disclosure statement</title><p>The authors declare no competing interests.</p></sec><sec sec-type="data-availability" disp-level="1" id="S0008"><title>Data availability statement</title><p>All relevant data supporting the findings of this study are included in the main text and supplementary materials. Additional data will be made available on request.</p></sec><ref-list><title>References</title><ref id="CIT0001"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Alghamdi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Almuqbil</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Alrofaidi</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Burzangi</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Alshamrani</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Alzahrani</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Kamal</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Imran</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Alshehri</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mannasaheb</surname>
<given-names>BA</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2022</year>. <article-title>Potential antioxidant activity of apigenin in the obviating stress-mediated depressive symptoms of experimental mice</article-title>. <source>Molecules</source>. <volume>27</volume>(<issue>24</issue>):<fpage>9055</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules27249055</pub-id>.<pub-id pub-id-type="pmid">36558188</pub-id>
</mixed-citation></ref><ref id="CIT0002"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Al-Yamani</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Mohammed Basheeruddin Asdaq</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Alamri</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Alsanie</surname>
<given-names>WF</given-names></string-name>, <string-name><surname>Alhomrani</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Alsalman</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Al Mohaini</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Al Hawaj</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Alanazi</surname>
<given-names>AA</given-names></string-name>, <string-name><surname>Alanzi</surname>
<given-names>KD</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2022</year>. <article-title>The role of serotonergic and catecholaminergic systems for possible antidepressant activity of apigenin</article-title>. <source>Saudi J Biol Sci</source>. <volume>29</volume>(<issue>1</issue>):<fpage>11</fpage>&#x02013;<lpage>17</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.sjbs.2021.11.008</pub-id>.<pub-id pub-id-type="pmid">35002391</pub-id>
</mixed-citation></ref><ref id="CIT0003"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Can</surname>
<given-names>&#x000d6;D</given-names></string-name>, <string-name><surname>Demir &#x000d6;zkay</surname>
<given-names>&#x000dc;</given-names></string-name>, <string-name><surname>&#x000dc;&#x000e7;el</surname>
<given-names>U&#x00130;.</given-names></string-name></person-group>
<year>2013</year>. <article-title>Anti-depressant-like effect of vitexin in BALB/c mice and evidence for the involvement of monoaminergic mechanisms</article-title>. <source>Eur J Pharmacol</source>. <volume>699</volume>(<issue>1-3</issue>):<fpage>250</fpage>&#x02013;<lpage>257</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejphar.2012.10.017</pub-id>.<pub-id pub-id-type="pmid">23099258</pub-id>
</mixed-citation></ref><ref id="CIT0004"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Colucci-D&#x02019;Amato</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Speranza</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Volpicelli</surname>
<given-names>F.</given-names></string-name></person-group>
<year>2020</year>. <article-title>Neurotrophic factor BDNF, physiological functions and therapeutic potential in depression, neurodegeneration and brain cancer</article-title>. <source>Int J Mol Sci</source>. <volume>21</volume>(<issue>20</issue>):<fpage>7777</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms21207777</pub-id>.<pub-id pub-id-type="pmid">33096634</pub-id>
</mixed-citation></ref><ref id="CIT0005"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dean</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Keshavan</surname>
<given-names>M.</given-names></string-name></person-group>
<year>2017</year>. <article-title>The neurobiology of depression: an integrated view</article-title>. <source>Asian J Psychiatr</source>. <volume>27</volume>:<fpage>101</fpage>&#x02013;<lpage>111</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ajp.2017.01.025</pub-id>.<pub-id pub-id-type="pmid">28558878</pub-id>
</mixed-citation></ref><ref id="CIT0006"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guo</surname>
<given-names>LT</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>SQ</given-names></string-name>, <string-name><surname>Su</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>LX</given-names></string-name>, <string-name><surname>Ji</surname>
<given-names>ZY</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>RY</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>QW</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>ZQ</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>XY</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>SP.</given-names></string-name></person-group>
<year>2019</year>. <article-title>Baicalin ameliorates neuroinflammation-induced depressive-like behavior through inhibition of toll-like receptor 4 expression via the PI3K/AKT/FoxO1 pathway</article-title>. <source>J Neuroinflammation</source>. <volume>16</volume>(<issue>1</issue>):<fpage>95</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12974-019-1474-8</pub-id>.<pub-id pub-id-type="pmid">31068207</pub-id>
</mixed-citation></ref><ref id="CIT0007"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Guyatt</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Oxman</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Akl</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Kunz</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Vist</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Brozek</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Norris</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Falck-Ytter</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Glasziou</surname>
<given-names>P</given-names></string-name>, <string-name><surname>DeBeer</surname>
<given-names>H</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2011</year>. <article-title>GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables</article-title>. <source>J Clin Epidemiol</source>. <volume>64</volume>(<issue>4</issue>):<fpage>383</fpage>&#x02013;<lpage>394</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jclinepi.2010.04.026</pub-id>.<pub-id pub-id-type="pmid">21195583</pub-id>
</mixed-citation></ref><ref id="CIT0008"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hammen</surname>
<given-names>C.</given-names></string-name></person-group>
<year>2018</year>. <article-title>Risk factors for depression: an autobiographical review</article-title>. <source>Annu Rev Clin Psychol</source>. <volume>14</volume>(<issue>1</issue>):<fpage>1</fpage>&#x02013;<lpage>28</lpage>. doi: <pub-id pub-id-type="doi">10.1146/annurev-clinpsy-050817-084811</pub-id>.<pub-id pub-id-type="pmid">29328780</pub-id>
</mixed-citation></ref><ref id="CIT0009"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Harmer</surname>
<given-names>CJ</given-names></string-name>, <string-name><surname>Duman</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Cowen</surname>
<given-names>PJ.</given-names></string-name></person-group>
<year>2017</year>. <article-title>How do antidepressants work? New perspectives for refining future treatment approaches</article-title>. <source>Lancet Psychiatry</source>. <volume>4</volume>(<issue>5</issue>):<fpage>409</fpage>&#x02013;<lpage>418</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2215-0366(17)30015-9</pub-id>.<pub-id pub-id-type="pmid">28153641</pub-id>
</mixed-citation></ref><ref id="CIT0010"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Herrman</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Kieling</surname>
<given-names>C</given-names></string-name>, <string-name><surname>McGorry</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Horton</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Sargent</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Patel</surname>
<given-names>V.</given-names></string-name></person-group>
<year>2019</year>. <article-title>Reducing the global burden of depression: a lancet-world psychiatric association commission</article-title>. <source>Lancet</source>. <volume>393</volume>(<issue>10189</issue>):<fpage>e42</fpage>&#x02013;<lpage>e43</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(18)32408-5</pub-id>.<pub-id pub-id-type="pmid">30482607</pub-id>
</mixed-citation></ref><ref id="CIT0011"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hooijmans</surname>
<given-names>CR</given-names></string-name>, <string-name><surname>Rovers</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>de Vries</surname>
<given-names>RB</given-names></string-name>, <string-name><surname>Leenaars</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ritskes-Hoitinga</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Langendam</surname>
<given-names>MW.</given-names></string-name></person-group>
<year>2014</year>. <article-title>SYRCLE&#x02019;s risk of bias tool for animal studies</article-title>. <source>BMC Med Res Methodol</source>. <volume>14</volume>(<issue>14</issue>):<fpage>43</fpage>. doi: <pub-id pub-id-type="doi">10.1186/1471-2288-14-43</pub-id>.<pub-id pub-id-type="pmid">24667063</pub-id>
</mixed-citation></ref><ref id="CIT0012"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jia</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Hou</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>X.</given-names></string-name></person-group>
<year>2023</year>. <article-title>Flavonoids for depression and anxiety: a systematic review and meta-analysis</article-title>. <source>Crit Rev Food Sci Nutr</source>. <volume>63</volume>(<issue>27</issue>):<fpage>8839</fpage>&#x02013;<lpage>8849</lpage>. doi: <pub-id pub-id-type="doi">10.1080/10408398.2022.2057914</pub-id>.<pub-id pub-id-type="pmid">35400250</pub-id>
</mixed-citation></ref><ref id="CIT0013"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jia</surname>
<given-names>ZX</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Cao</surname>
<given-names>ZQ</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Chu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>SD</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Pei</surname>
<given-names>L.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Baicalin ameliorates chronic unpredictable mild stress-induced depression through the BDNF/ERK/CREB signaling pathway</article-title>. <source>Behav Brain Res</source>. <volume>24</volume>(<issue>414</issue>):<fpage>113463</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbr.2021.113463</pub-id>.</mixed-citation></ref><ref id="CIT0014"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jin</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Bai</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y.</given-names></string-name></person-group>
<year>2023</year>. <article-title>Baicalin ameliorates CUMS-induced depression-like behaviors through activating AMPK/PGC-1&#x003b1; pathway and enhancing NIX-mediated mitophagy in mice</article-title>. <source>Eur J Pharmacol</source>. <volume>5</volume>(<issue>938</issue>):<fpage>175435</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejphar.2022.175435</pub-id>.</mixed-citation></ref><ref id="CIT0015"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khan</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Perviz</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Sureda</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nabavi</surname>
<given-names>SM</given-names></string-name>, <string-name><surname>Tejada</surname>
<given-names>S.</given-names></string-name></person-group>
<year>2018</year>. <article-title>Current standing of plant derived flavonoids as an antidepressant</article-title>. <source>Food Chem Toxicol</source>. <volume>119</volume>:<fpage>176</fpage>&#x02013;<lpage>188</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.fct.2018.04.052</pub-id>.<pub-id pub-id-type="pmid">29704578</pub-id>
</mixed-citation></ref><ref id="CIT0016"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ko</surname>
<given-names>YH</given-names></string-name>, <string-name><surname>Kim</surname>
<given-names>SK</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>SY</given-names></string-name>, <string-name><surname>Jang</surname>
<given-names>CG.</given-names></string-name></person-group>
<year>2020</year>. <article-title>Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression</article-title>. <source>Arch Pharm Res</source>. <volume>43</volume>(<issue>11</issue>):<fpage>1128</fpage>&#x02013;<lpage>1143</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12272-020-01292-5</pub-id>.<pub-id pub-id-type="pmid">33225387</pub-id>
</mixed-citation></ref><ref id="CIT0017"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Yao</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>LL.</given-names></string-name></person-group>
<year>2024</year>. <article-title>Quercetin reshapes gut microbiota homeostasis and modulates brain metabolic profile to regulate depression-like behaviors induced by CUMS in rats</article-title>. <source>Front Pharmacol</source>. <volume>15</volume>:<fpage>1362464</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2024.1362464</pub-id>.<pub-id pub-id-type="pmid">38595919</pub-id>
</mixed-citation></ref><ref id="CIT0018"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>J.</given-names></string-name></person-group>
<year>2022</year>. <article-title>Traditional Chinese medicine in treating hypertension</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <volume>15</volume>(<issue>3</issue>):<fpage>e008723</fpage>. doi: <pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.121.008723</pub-id>.<pub-id pub-id-type="pmid">35105174</pub-id>
</mixed-citation></ref><ref id="CIT0019"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Qu</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>Q</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>S.</given-names></string-name></person-group>
<year>2015a</year>. <article-title>The effects of apigenin on lipopolysaccharide-induced depressive-like behavior in mice</article-title>. <source>Neurosci Lett</source>. <volume>594</volume>:<fpage>17</fpage>&#x02013;<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.neulet.2015.03.040</pub-id>.<pub-id pub-id-type="pmid">25800110</pub-id>
</mixed-citation></ref><ref id="CIT0020"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Pei</surname>
<given-names>YY</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>HB</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>BY</given-names></string-name>, <string-name><surname>Bai</surname>
<given-names>M.</given-names></string-name></person-group>
<year>2015b</year>. <article-title>Baicalin decreases SGK1 expression in the hippocampus and reverses depressive-like behaviors induced by corticosterone</article-title>. <source>Neuroscience</source>. <volume>17</volume>(<issue>311</issue>):<fpage>130</fpage>&#x02013;<lpage>137</lpage>.</mixed-citation></ref><ref id="CIT0021"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Li</surname>
<given-names>ZP</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>QC</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>ZH</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>XT</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yu</surname>
<given-names>YH.</given-names></string-name></person-group>
<year>2022</year>. <article-title>A20, as a downstream factor of Nrf2, is involved in the anti-neuroinflammatory and antidepressant-like effects of luteolin</article-title>. <source>J Funct Foods</source>. <volume>99</volume>:<fpage>105305</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jff.2022.105305</pub-id>.</mixed-citation></ref><ref id="CIT0022"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>HT</given-names></string-name>, <string-name><surname>Lin</surname>
<given-names>YN</given-names></string-name>, <string-name><surname>Tsai</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>MC.</given-names></string-name></person-group>
<year>2022a</year>. <article-title>Baicalein exerts therapeutic effects against endotoxin-induced depression-like behavior in mice by decreasing inflammatory cytokines and increasing brain-derived neurotrophic factor levels</article-title>. <source>Antioxidants</source>. <volume>11</volume>(<issue>5</issue>):<fpage>947</fpage>. doi: <pub-id pub-id-type="doi">10.3390/antiox11050947</pub-id>.<pub-id pub-id-type="pmid">35624812</pub-id>
</mixed-citation></ref><ref id="CIT0023"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Dong</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Shan</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Xia</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>H.</given-names></string-name></person-group>
<year>2019</year>. <article-title>Anti-depressive effectiveness of baicalin in vitro and in vivo</article-title>. <source>Molecules</source>. <volume>24</volume>(<issue>2</issue>):<fpage>326</fpage>. doi: <pub-id pub-id-type="doi">10.3390/molecules24020326</pub-id>.<pub-id pub-id-type="pmid">30658416</pub-id>
</mixed-citation></ref><ref id="CIT0024"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>B.</given-names></string-name></person-group>
<year>2015</year>. <article-title>Herbal medicine for anxiety, depression and insomnia</article-title>. <source>Curr Neuropharmacol</source>. <volume>13</volume>(<issue>4</issue>):<fpage>481</fpage>&#x02013;<lpage>493</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1570159x1304150831122734</pub-id>.<pub-id pub-id-type="pmid">26412068</pub-id>
</mixed-citation></ref><ref id="CIT0025"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Pu</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ji</surname>
<given-names>P</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2022b</year>. <article-title>Toward a deeper understanding of gut microbiome in depression: the promise of clinical applicability</article-title>. <source>Adv Sci (Weinh)</source>. <volume>9</volume>(<issue>35</issue>):<fpage>e2203707</fpage>. doi: <pub-id pub-id-type="doi">10.1002/advs.202203707</pub-id>.<pub-id pub-id-type="pmid">36285702</pub-id>
</mixed-citation></ref><ref id="CIT0026"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Zeng</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Dai</surname>
<given-names>F.</given-names></string-name></person-group>
<year>2023</year>. <article-title>Association between depression and oxidative balance score: national Health and Nutrition Examination Survey (NHANES) 2005-2018</article-title>. <source>J Affect Disord</source>. <volume>15</volume>(<issue>337</issue>):<fpage>57</fpage>&#x02013;<lpage>65</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jad.2023.05.071</pub-id>.</mixed-citation></ref><ref id="CIT0027"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Lan</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Gou</surname>
<given-names>LS</given-names></string-name>, <string-name><surname>Fu</surname>
<given-names>XB</given-names></string-name>, <string-name><surname>Cui</surname>
<given-names>W.</given-names></string-name></person-group>
<year>2013</year>. <article-title>Improvement effect of luteolin on depression induced by chronic unpredictable mild stress in mice</article-title>. <source>Lishizhen Med Meter Med Res</source>. <volume>24</volume>(<issue>6</issue>):<fpage>1382</fpage>&#x02013;<lpage>1384</lpage>.</mixed-citation></ref><ref id="CIT0028"><mixed-citation publication-type="journal"><person-group person-group-type="author">Liu YY, Lu Y, Chu L, Guan ZW, Bai WZ, Pei Lin, Zhao YN, Chen YF.</person-group>
<year>2019</year>. <article-title>Effects of Baicalin on expression of calbindin-D28K in hippocampus of depression model mice</article-title>. Chin J New Drugs Clin Rem. <volume>38</volume>(<issue>2</issue>):<fpage>107</fpage>&#x02013;<lpage>111</lpage>.</mixed-citation></ref><ref id="CIT0029"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname>
<given-names>SF</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Jin</surname>
<given-names>XH</given-names></string-name>, <string-name><surname>Zhu</surname>
<given-names>LL</given-names></string-name>, <string-name><surname>Shen</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Bai</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>YC</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>ER.</given-names></string-name></person-group>
<year>2022</year>. <article-title>Baicalin improves the energy levels in the prefrontal cortex of mice exposed to chronic unpredictable mild stress</article-title>. <source>Heliyon</source>. <volume>8</volume>(<issue>12</issue>):<fpage>e12083</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.heliyon.2022.e12083</pub-id>.<pub-id pub-id-type="pmid">36531636</pub-id>
</mixed-citation></ref><ref id="CIT0030"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>GQ</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Guan</surname>
<given-names>ZW</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>YY</given-names></string-name>, <string-name><surname>Chu</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Pei</surname>
<given-names>L.</given-names></string-name></person-group>
<year>2019</year>. <article-title>Baicalin regulates depression behavior in mice exposed to chronic mild stress via the Rac/LIMK/cofilin pathway</article-title>. <source>Biomed Pharmacother</source>. <volume>116</volume>(<issue>5</issue>):<fpage>109054</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2019.109054</pub-id>.<pub-id pub-id-type="pmid">31176122</pub-id>
</mixed-citation></ref><ref id="CIT0031"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lysrayane</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Mateus</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Isaac</surname>
<given-names>C.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Systematic review of the antidepressant activity and associated antioxidant and anti-inflammatory effects of flavonoids in rodents</article-title>. <source>Res Soc Dev</source>. <volume>10</volume>(<issue>12</issue>):<fpage>Cd008851</fpage>.</mixed-citation></ref><ref id="CIT0032"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ma</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Feng</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Rui</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Z.</given-names></string-name></person-group>
<year>2023</year>. <article-title>Baicalin attenuates chronic unpredictable mild stress-induced hippocampal neuronal apoptosis through regulating SIRT1/PARP1 signaling pathway</article-title>. <source>Behav Brain Res</source>. <volume>441</volume>:<fpage>114299</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbr.2023.114299</pub-id>.<pub-id pub-id-type="pmid">36642102</pub-id>
</mixed-citation></ref><ref id="CIT0033"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Melrose</surname>
<given-names>J.</given-names></string-name></person-group>
<year>2023</year>. <article-title>The potential of flavonoids and flavonoid metabolites in the treatment of neurodegenerative pathology in disorders of cognitive decline</article-title>. <source>Antioxidants</source>. <volume>12</volume>(<issue>3</issue>):<fpage>663</fpage>. doi: <pub-id pub-id-type="doi">10.3390/antiox12030663</pub-id>.<pub-id pub-id-type="pmid">36978911</pub-id>
</mixed-citation></ref><ref id="CIT0034"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Page</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>McKenzie</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Bossuyt</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Boutron</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Hoffmann</surname>
<given-names>TC</given-names></string-name>, <string-name><surname>Mulrow</surname>
<given-names>CD</given-names></string-name>, <string-name><surname>Shamseer</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Tetzlaff</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Akl</surname>
<given-names>EA</given-names></string-name>, <string-name><surname>Brennan</surname>
<given-names>SE</given-names></string-name>, <etal>et&#x000a0;al.</etal></person-group>
<year>2021</year>. <article-title>The PRISMA 2020 statement: an updated guideline for reporting systematic reviews</article-title>. <source>BMJ</source>. <volume>372</volume>:<fpage>n71</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id>.<pub-id pub-id-type="pmid">33782057</pub-id>
</mixed-citation></ref><ref id="CIT0035"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Peng</surname>
<given-names>GJ</given-names></string-name>, <string-name><surname>Tian</surname>
<given-names>JS</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>XX</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>YZ</given-names></string-name>, <string-name><surname>Qin</surname>
<given-names>XM.</given-names></string-name></person-group>
<year>2015</year>. <article-title>Research on the pathological mechanism and drug treatment mechanism of depression</article-title>. <source>Curr Neuropharmacol</source>. <volume>13</volume>(<issue>4</issue>):<fpage>514</fpage>&#x02013;<lpage>523</lpage>. doi: <pub-id pub-id-type="doi">10.2174/1570159x1304150831120428</pub-id>.<pub-id pub-id-type="pmid">26412071</pub-id>
</mixed-citation></ref><ref id="CIT0036"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Yin</surname>
<given-names>F.</given-names></string-name></person-group>
<year>2021</year>. <article-title>The mechanisms and clinical application of traditional chinese medicine lianhua-qingwen capsule</article-title>. <source>Biomed Pharmacother</source>. <volume>142</volume>(<issue>2</issue>):<fpage>111998</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2021.111998</pub-id>.<pub-id pub-id-type="pmid">34385103</pub-id>
</mixed-citation></ref><ref id="CIT0037"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sheng</surname>
<given-names>JD</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>CY</given-names></string-name>, <string-name><surname>Wei</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>L.</given-names></string-name></person-group>
<year>2016</year>. <article-title>Effects of baicalin on the expression of NT-3 in hippocampus of mice with depression induced by corticosterone</article-title>. <source>Chin J Ethnomed Ethnophar</source>. <volume>25</volume>(<issue>20</issue>):<fpage>13</fpage>&#x02013;<lpage>15</lpage>.</mixed-citation></ref><ref id="CIT0038"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Solmi</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Fornaro</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ostinelli</surname>
<given-names>EG</given-names></string-name>, <string-name><surname>Zangani</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Croatto</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Monaco</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Krinitski</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Fusar-Poli</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Correll</surname>
<given-names>CU.</given-names></string-name></person-group>
<year>2020</year>. <article-title>Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects</article-title>. <source>World Psychiatry</source>. <volume>19</volume>(<issue>2</issue>):<fpage>214</fpage>&#x02013;<lpage>232</lpage>. doi: <pub-id pub-id-type="doi">10.1002/wps.20765</pub-id>.<pub-id pub-id-type="pmid">32394557</pub-id>
</mixed-citation></ref><ref id="CIT0039"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Mi</surname>
<given-names>LF</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>ZL</given-names></string-name>, <string-name><surname>Hu</surname>
<given-names>MZ</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>ZY</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>YB</given-names></string-name>, <string-name><surname>Zheng</surname>
<given-names>S.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Saikosaponin A improved depression-like behavior and inhibited hippocampal neuronal apoptosis after cerebral ischemia through p-CREB/BDNF pathway</article-title>. <source>Behav Brain Res</source>. <volume>403</volume>(<issue>5</issue>):<fpage>113138</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bbr.2021.113138</pub-id>.<pub-id pub-id-type="pmid">33493495</pub-id>
</mixed-citation></ref><ref id="CIT0040"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Gao</surname>
<given-names>MQ.</given-names></string-name></person-group>
<year>2024</year>. <article-title>Research progress on the antidepressant effects of baicalin and its aglycone baicalein: a systematic review of the biological mechanisms</article-title>. <source>Neurochem Res</source>. <volume>49</volume>(<issue>1</issue>):<fpage>14</fpage>&#x02013;<lpage>28</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11064-023-04026-3</pub-id>.<pub-id pub-id-type="pmid">37715823</pub-id>
</mixed-citation></ref><ref id="CIT0041"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Cheng</surname>
<given-names>YT</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>GQ</given-names></string-name>, <string-name><surname>Pei</surname>
<given-names>L.</given-names></string-name></person-group>
<year>2023</year>. <article-title>Baicalin ameliorates corticosterone-induced depression by promoting neurodevelopment of hippocampal via mTOR/GSK3 &#x003b2; pathway</article-title>. <source>Chin J Integr Med</source>. <volume>29</volume>(<issue>5</issue>):<fpage>405</fpage>&#x02013;<lpage>412</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11655-022-3590-z</pub-id>.<pub-id pub-id-type="pmid">36607586</pub-id>
</mixed-citation></ref><ref id="CIT0042"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weng</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Han</surname>
<given-names>Y.</given-names></string-name></person-group>
<year>2016</year>. <article-title>Apigenin reverses depression-like behavior induced by chronic corticosterone treatment in mice</article-title>. <source>Eur J Pharmacol</source>. <volume>774</volume>(<issue>6</issue>):<fpage>50</fpage>&#x02013;<lpage>54</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ejphar.2016.01.015</pub-id>.<pub-id pub-id-type="pmid">26826594</pub-id>
</mixed-citation></ref><ref id="CIT0043"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Xiao</surname>
<given-names>ZG</given-names></string-name>, <string-name><surname>Cao</surname>
<given-names>ZQ</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Jia</surname>
<given-names>ZX</given-names></string-name>, <string-name><surname>Du</surname>
<given-names>YR</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>GQ</given-names></string-name>, <string-name><surname>Lu</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Pei</surname>
<given-names>L.</given-names></string-name></person-group>
<year>2021</year>. <article-title>Baicalin promotes hippocampal neurogenesis via the Wnt/beta-catenin pathway in a chronic unpredictable mild stress-induced mouse model of depression</article-title>. <source>Biochem Pharmacol</source>. <volume>190</volume>(<issue>2</issue>):<fpage>114594</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.bcp.2021.114594</pub-id>.<pub-id pub-id-type="pmid">33964281</pub-id>
</mixed-citation></ref><ref id="CIT0044"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ming</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Qian</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Peng</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Ding</surname>
<given-names>Y.</given-names></string-name></person-group>
<year>2023</year>. <article-title>Herbal medicine as adjunctive therapy with antidepressants for post-stroke depression: a systematic review and network meta-analysis of randomized controlled trials</article-title>. <source>Front Pharmacol</source>. <volume>14</volume>(<issue>14</issue>):<fpage>1180071</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2023.1180071</pub-id>.<pub-id pub-id-type="pmid">37521479</pub-id>
</mixed-citation></ref><ref id="CIT0045"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>K</given-names></string-name>, <string-name><surname>He</surname>
<given-names>MY</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>HT</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>YT</given-names></string-name>, <string-name><surname>Yang</surname>
<given-names>JY</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>CF.</given-names></string-name></person-group>
<year>2019a</year>. <article-title>Revealing antidepressant mechanisms of baicalin in hypothalamus through systems approaches in corticosterone-induced depressed mice</article-title>. <source>Front Neurosci</source>. <volume>13</volume>(<issue>2</issue>):<fpage>834</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fnins.2019.00834</pub-id>.<pub-id pub-id-type="pmid">31440134</pub-id>
</mixed-citation></ref><ref id="CIT0046"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>RY</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>ZX</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>YW</given-names></string-name>, <string-name><surname>Liu</surname>
<given-names>DN</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>LX</given-names></string-name>, <string-name><surname>Deng</surname>
<given-names>XY</given-names></string-name>, <string-name><surname>Qu</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>ZQ</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>SP.</given-names></string-name></person-group>
<year>2019b</year>. <article-title>Baicalin exerts antidepressant effects through Akt/FOXG1 pathway promoting neuronal differentiation and survival</article-title>. <source>Life Sci</source>. <volume>15</volume>(<issue>221</issue>):<fpage>241</fpage>&#x02013;<lpage>248</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.lfs.2019.02.033</pub-id>.</mixed-citation></ref><ref id="CIT0047"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Bu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Sun</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Jiang</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Duan</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Huang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>Q.</given-names></string-name></person-group>
<year>2019c</year>. <article-title>The antidepressant effects of apigenin are associated with the promotion of autophagy via the mTOR/AMPK/ULK1 pathway</article-title>. <source>Mol Med Rep</source>. <volume>20</volume>(<issue>3</issue>):<fpage>2867</fpage>&#x02013;<lpage>2874</lpage>. doi: <pub-id pub-id-type="doi">10.3892/mmr.2019.10491</pub-id>.<pub-id pub-id-type="pmid">31322238</pub-id>
</mixed-citation></ref><ref id="CIT0048"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Tao</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Shang</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Ruan</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Zhang</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Aiello</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Lai</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Qu</surname>
<given-names>R.</given-names></string-name></person-group>
<year>2020</year>. <article-title>Facilitating granule cell survival and maturation in dentate gyrus with baicalin for antidepressant therapeutics</article-title>. <source>Front Pharmacol</source>. <volume>2</volume>(<issue>11</issue>):<fpage>556845</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fphar.2020.556845</pub-id>.</mixed-citation></ref><ref id="CIT0049"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhong</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Li</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Xu</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>M.</given-names></string-name></person-group>
<year>2019</year>. <article-title>Baicalin ameliorates chronic mild stress-induced depression-like behaviors in mice and attenuates inflammatory cytokines and oxidative stress</article-title>. <source>Braz J Med Biol Res</source>. <volume>52</volume>(<issue>7</issue>):<fpage>e8434</fpage>. doi: <pub-id pub-id-type="doi">10.1590/1414-431X20198434</pub-id>.<pub-id pub-id-type="pmid">31241715</pub-id>
</mixed-citation></ref><ref id="CIT0050"><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhu</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wang</surname>
<given-names>LP</given-names></string-name>, <string-name><surname>Wan</surname>
<given-names>Q.</given-names></string-name></person-group>
<year>2022</year>. <article-title>Therapeutic targets of neuroprotection and neurorestoration in ischemic stroke: applications for natural compounds from medicinal herbs</article-title>. <source>Biomed Pharmacother</source>. <volume>148</volume>:<fpage>112719</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.biopha.2022.112719</pub-id>.<pub-id pub-id-type="pmid">35168073</pub-id>
</mixed-citation></ref></ref-list></back></article>